  |
  |
Posters
| TOPIC 01.1 |
| Topic 01.1. |
| Blood Safety - TTD - HIV |
| P-001 IMPLEMENTATION OF HIV P24 ANTIGEN AND ANTIBODY COMBINED SCREENING ASSAYS IN BLOOD TRANSFUSION INSTITUTE NOVI SAD |
| S. Bogdanovic, N. Bujandric, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia and Montenegro) |
| P-002 USING THE HARMONIC MEAN TO ESTIMATE BLOOD DONORS RECENTLY INFECTED BY HIV AND TO CALCULATE THE RISK THEY POSE TO THE SOUTH AFRICAN BLOOD SUPPLY |
| G.C. Buckle, G.L. Webb (N.A., Pennington, South Africa) |
| P-003 HTLV I/II INFECTION IN BLOOD DONORS: SEROPREVALENCE AND PERFORMANCE OF DIFFERENT KITS |
| A.O. Chiera, G. Larranaga, C. Bonacina, N. Etchenique (Hemotherapy Institute of Buenos Aires Pr, La Plata. Provincia De Buenos Aires, Argentina) |
| P-004 PATTERNS OF BLOOD PRODUCT TRANSFUSION AT A TERTIARY GYNAECOLOGY UNIT |
| Ndlovu J., Dreyer G (University of Pretoria, Pretoria, South Africa) |
| P-005 SURVEILLANCE OF TRANSFUSION TRANSMITTE INFECTION IN FIRST TIME BLOOD DONORS |
| V. Durro, A. Abazaj, S. Spahiu, S. Seferi (NBTSA, Tirana, Albania) |
| P-006 BLOOD DONORING, PROGRESS IN THE TESTING ON HIV VIRUS |
| C. Gavrancic, B. Gavrancic, T. Jakica (Blood Transfusion Institute, Novi Sad, Yugoslavia) |
| P-007 THE PREVALENCE OF HUMAN HERPESVIRUS 8 (HHV-8) AMONG TEHRAN BLOOD DONORS, HAEMODIALYSIS PATIENTS, AND HIV POSITIVE INDIVIDUALS |
| A. Gharehbaghian, A. Zaghal, M. Farhadi Langerudi, S. Sadri (The Research Center of IBTO, Tehran, Iran) |
| P-008 COST-EFFECTIVENESS OF HIV SCREENING OF BLOOD DONATIONS IN GHANA |
| M. van Hulst, K.W.C. Sagoe, J.E. Vermande, W.P.A. Van der Tuuk Adriani, E.K. Torpey, J. Ansah, J.A. Mingle, C.Th. Smit Sibinga, M.J. Postma (GUIDE/Martini Hospital, Groningen, Netherlands) |
| P-009 TRENDS IN INCIDENCE OF MAJOR TRANSFUSION TRANSMISSIBLE VIRAL INFECTION IN FARS BLOOD DONORS FROM 2002 TILL END OF 2006 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-010 A SURVEY OF EPIDEMIOLOGICAL STATUS AND PREVALENCE RATE OF HIV CASES IN BLOOD DONORS DURING 2005 IN SHIRAZ BLOOD TRANSFUSION ORGANIZATION |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-011 RISK BEHAVIOR AMONG BLOOD DONORS WHO GIVE BLOOD IN ORDER TO BE TESTED FOR HIV IN SHIRAZ BLOOD TRANSFUSION IN 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-012 REDUCING THE RISK OF BLOOD BORNE TRANSMISSION HBS, HCV AND HIV THROUGH BLOOD TRANSFUSION BY DONOR SELF-DEFERRAL |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (Ibto Research Center, Shiraz, Iran) |
| P-013 THE TRANSFORMATION OF THE BOTSWANA NATIONAL BLOOD TRANSFUSION SERVICE |
| M.K.A. Kayembe, C. Pule, C.I. Tema, J. van Hasselt, S.M. Gaolekwe, B. Gibbs (National Health Laboratory, Gaborone, Botswana) |
| P-014 PREVALENCE OF BLOOD BORNE DISEASE MARKERS AND RESIDUAL RISK IN BLOOD DONORS AT CROATIAN INSTITUTE OF TRANSFUSION MEDICINE 1995-2005 |
| L.M. Lovric, I. Mihaljevic, K. Strahija Tomic, B.M. Balija, J.I. Jukic (Croatian Institute of Transfusion Medici, Zagreb, Croatia) |
| P-015 A REVIEW OF BLOOD DONOR RISK MODEL IN ZIMBABWE |
| T. Mapako, A. Mvere (National Blood Service Zimbabwe, Harare, Zimbabwe) |
| P-016 AN ANALYSIS OF HIV RISK FACTORS FROM POST-DONATION COUNSELLING RECORDS |
| T. Mapako, S. Shamu, A. Mvere, J. Parirewa (National Blood Service Zimbabwe, Harare, Zimbabwe) |
| P-017 HIV-1 INCIDENCE IN BLOOD DONORS IN FRANCE BETWEEN 1992 AND 2004: USE OF AN IMMUNOASSAY TO IDENTIFY RECENT INFECTIONS |
| J.P. Pillonel, F. Barin, S. Laperche, P. Bernillon, S. le Vu, B. Liandier, G. Andreu, J.C. Desenclos (Institut de Veille Sanitaire, Saint-Maurice, France) |
| P-018 DETECTION OF HIV-1 INFECTION IN BLOOD DONORS DURING THE IMMUNOLOGICAL WINDOW PERIOD BY THE IMPLEMENTATION OF NUCLEIC ACID AMPLIFICATION TECHNOLOGY |
| P.S.P. Scuracchio, A.G. Oliveira Filho, M.M.M. Lemos, M.C.C. Poli, R. Colella, M.M.C. Magri, N.J.F. Cavalcanti, E.C. Sabino, N.A. Salles, D.A.F. Chamone (Banco de Sangue de Sao Paulo, São Paulo, Brazil) |
| P-019 A STATISTICAL DONOR STATUS MODEL THAT MINIMISES THE RISK OF TRANSFUSION-TRANSMITTED HIV IN SOUTH AFRICA |
| J.P. Swanevelder, A. Heyns, R. Reddy, M.P. Busch (South African National Blood Service (SANBS), Roodepoort (Johannesburg), South Africa) |
| P-020 COPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS B VIRUS AMONG VOLUNTEER BLOOD DONORS |
| B. Tiwari, P. Ghimire (Central Blood Transfusion Service, Kathmandu, Nepal) |
| P-021 DOES A HIGH RESULT FOR A QUALITY CONTROL SAMPLE INDICATE A HIGHER FALSE REACTOR RATE IN THE ABBOTT PRISM ASSAYS USED FOR BLOOD DONOR SCREENING? |
| S.K. Walker, B. Francis, K. Smeh, S. Ismay, E.M. Dax, M. Karakaltsas (National Serology Reference Laboratory, Fitzroy, Australia) |
| P-022 TRENDS IN INCIDENCE AND PREVALENCE OF MAJOR TRANSFUSIONTRANSMISSIBLE VIRAL INFECTIONS IN UKRAINIAN BLOOD DONORS |
| M. Zadorin (Clinical research Institute, Kiev, Ukraine) |
| P-023 C-REACTIVE PROTEIN IN HIV POSITIVE SUBJECTS |
| F. Tarabadi, M. Mostakhdemi, M. Shaeigan, G. Babaei, M. Aghaeepour (Iranian Blood Transfusion Organization R, Tehran, Iran) |
| P-024 SOME HEMATOLOGICAL PARAMETERS IN HIV-AIDS PATIENTS IN ILE-IFE, NIGERIA |
| A.O. Adeloye, M.A. Durosinmi (Obafemi Awolowo University, Ile-ife, Nigeria) |
| TOPIC 01.2 |
| Topic 01.2. |
| Blood Safety - TTD - Hepatitis |
| P-025 UTILITY OF SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS ANTIGEN AND ANTIBODIES IN HEMODIALYSIS PATIENTS. |
| J.C. Alados Arboledas, L. Calbo, S. de Tena, M.D. Lopez, J.L. de Francisco, C. de Miguel (Hospital Del Sas De Jerez, Jerez De La Frontera (Cadiz, Spain) |
| P-026 INCIDENCE OF HBSAG, ANTI-HCV, ANTI-HIV ANTIBODIES IN BLOOD DONORS IN OHRID MUNICIPALITY-REPUBLIC OF MACEDONIA |
| A.M. Aleksioska (Medical Center, Ohrid, Macedonia) |
| P-029 EPIDEMIOLOGICAL INVESTIGATION OF TRANSFUSION TRANSMISSIBLE INFECTIONS IN BULGARIA |
| S. Bakalova, P. Kirova, A. Slivov (National Center of Hematology and Transfusion, Sofia, Bulgaria) |
| P-030 THE ELEVATED ALANINE AMINOTRANSFERASE AND HEPATITIS IN BLOOD DONORS |
| E. Berberi, N. Borici, I. Seferi (National Blood Transfusion Centre, Tirana, Albania) |
| P-031 HEPATITIS B IN BLOOD DONORS: ANALYSIS OF TESTING RESULTS IN THE PERIOD 2000-2005 IN BLOOD TRANSFUSION INSTITUTE NOVI SAD |
| B.N. Bujandric, B.S. Bogdanovic, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia and Montenegro) |
| P-032 BENEFITS OF HCV ANTIGEN/ANTIBODY TESTING; A COMPARISON OF THE NEW ABBOTT MUREX HCV AG/AB COMBINATION ASSAY WITH ANTIBODY ONLY TESTING AND A COMPETITOR HCV COMBINATION ASSAY |
| J. Burch, B. Rodgers, J. James, N. Napier, E. Furze, H. Trencher, S. Blincko, D. Trotter, L. McBryne (Abbott Murex, Dartford, Kent, United Kingdom) |
| P-033 HEPATITIS B VIRUS GENOTYPES, CORE PROMOTER AND PRE-CORE MUTATIONS IN SCOTTISH BLOOD DONORS |
| F. Davidson, C. Lycett, E. Erwin, J. Petrik, B. Dow (Scottish National Blood Transfusion Serv, Edinburgh, United Kingdom) |
| P-034 DEVELOPMENT OF A NEW HEPATITIS B SURFACE ANTIGEN ASSAY WITH IMPROVED SENSITIVITY TO WILD TYPE AND VARIANT HBSAG FOR USE ON THE ORTHO CLINICAL DIAGNOSTICS VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM |
| A. Diment, M. van Cleve, S. Son, H. Todd, C. Ching, B. Herring, J. Zheng, P. Kilmartin (Ortho Clinical Diagnostics, High Wycombe, United Kingdom) |
| P-035 NAT HBV: TRANSFUSION SAFETY AND INFECTIVE RESIDUAL RISK |
| M. D'Onofrio, L. Paesano, E. Perna, S. Formisano (AOU "Federico II", Napoli, Italy) |
| P-036 SERO-PREVALENCE OF ANTI- HBC AND ANTI-HBS IN ECONOMIC IMMIGRANTS BLOOD DONORS IN A BLOOD TRANSFUSION CENTER |
| V. Fakitsa, K. Kourenti, M. Papakonstantinou, J. Chaniotis, A. Flangini, G. Lyrakos, P. Karida, B. Restermont, S. Stefanakou, E. Mpotsaki, E. Theologou, K. Sofraniadou (District General Hospital of Nikea, Athens, Greece) |
| P-037 EVALUATION OF THE INTRODUCTION OF OTHER MARKERS OF HEPATITIS B IN ROUTINE TESTING |
| K. Farmaki, C. Papa, I.T. Tzoumari, M.S. Sotiraki, A.C. Chrysanthou, M. Savvanos (General Hospital of Corinth, Corinth, Greece) |
| P-038 A PROTEOMIC APPROACH IN HUMAN PLASMA TO INVESTIGATE POTENTIAL BIOMARKERS FOR RESOLUTION OF ACUTE HEPATITIS C VIRUS INFECTION |
| C. Fournier-Wirth, S. Molina, D. Misse, F. Veas, P. Maurel, J. Coste, C. Fournier-Wirth (Etablissement Français du Sang, Montpellier, France) |
| P-039 POLYMORPHISM OF THE HLA-DQ5 PROMOTER REGION INFLUENCES HUMORAL IMMUNE RESPONSE IN HBSAG VACCINATION AND SISTEMIC LUPUS ERITHEMATOSUS |
| V. Galvani, V. Dolzan, B. Vidan-Jeras (General Hospital Izola, Izola, Slovenia) |
| P-040 PREVALENCE OF HBSAG, HCV, HIV AMONG POTENTIAL VOLUNTARY NON-REMUNERATED BLOOD DONORS: TWELVE YEARS OF OBSERVATION (1994-2005) |
| G. Garozzo, L. Morando, E. Parrino, G. Bussetti, P. Bonomo (Az. Ospedaliera Civile-Mparezzo, Ragusa, Italy) |
| P-041 HBV-DNA AND HBCAB IGG IN BLOOD DONORS’ POPULATION |
| G.P. Ghiazza, E. Cesale Ros, G. Cornagliotto, G. Demarin, G. Demarchi, V. Gariglio, R. Marinoni, A. Martinelli, M. Ricotti, M. Trive, F. Eliantonio, A. Garofalo, G. Ghisetti, M. Lupo, F. Palazzo, M. Palazzo, B. Tea, L. Albin (A.S.O. OIRM-S.Anna, Torino, Italy) |
| P-042 PREVALENCE OF TRANSFUSION-TRANSMISSIBLE VIRAL INFECTION IN FIRST-TIME BLOOD DONORS IN UNITED ARAB EMIRATES |
| H. Gohar (Sharjah Blood Transfusion Center, Sharjah, United Arab Emirates) |
| P-043 REACTIVITY OF GENOTYPICALLY DISTINCT HEPATITIS B VIRUS SURFACE B VIRUS ANTIGENS (HBSAG) BY AN AUTOMATED CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY |
| N.S.L. Gonçales, M.C. Favarelli, P.A. Tonetto, R.G.F. Domínguez, J.B.A. Neto, F.L. Goncales (University of Campinas-UNICAMP, Campinas, Brazil) |
| P-044 EVALUATION THE PERFORMANCE OF QUANTITATIVE HEPATITIS B SURFACE ANTIGEN (HBSAG) BY AN AUTOMATED CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY, IN A BRAZILIAN BLOOD BANK. |
| N.S.L. Gonçales, M.C. Favarelli, J.B.A. Neto, R.G.F. Domínguez, G.Q. Prado, R. Guedes (University of Campinas-UNICAMP, Campinas, Brazil) |
| P-045 DEVELOPMENT OF HUMAN ANTI-CMV IGG ASSAY FOR THE ARCHITECT ANALYZER |
| J. Herzogenrath, I. Curdt, H. Christ, S. Bernhardt, R. Stricker, R. Stricker, M. Hausmann (Abbott GmbH & Co. KG, Wiesbaden, Germany) |
| P-046 COMBINATION HEPATITIS C VIRUS ANTIGEN AND ANTIBODY IMMUNOASSAY AS A NEW TOOL FOR EARLY DIAGNOSIS OF INFECTION |
| G.C. Icardi, F. Ansaldi, C. Sticchi, C. Riccio, P. Lai, B. Bruzzone (University of Genoa, Genoa, Italy) |
| P-047 THE FIRST NATIONAL REPORT OF TT( TRANSFUSION TRANSMITTED) VIRUS PREVALENCE IN DIFFERENT RACIAL GROUPS ADMITTED TO AHWAZ TRANSFUSION SERVICE (IRAN) BY POLYMERASE CHAIN REACTION(PCR) |
| M.A. Jalali Far, T. Zanieh, S.A. Emam, A.A. Pourfathollah (IBTO Research Center, Ahwaz, Iran) |
| P-048 RELATION OF HEPATITIS C VIRUS (HCV) PREVALENCE, ABO AND RH BLOOD GROUPS AND OTHER RISK INDICATORS AMONG BLOOD DONORS IN PORT HARCOURT, NIGERIA |
| A. Jeremiah, B. Koate (Rivers State University of Sci & Tech, Port Harcourt, Nigeria) |
| P-049 EVALUATION OF THE ENHANCED ARCHITECT® ANTI-HCV ASSAY FOR DONOR SCREENING |
| G. Jonas, C. Beckert, C. Pelzer, M. Hausmann, H.-P. Kapprell (Abbott GmbH & Co. KG, Wiesbaden, Germany) |
| P-050 A CASE CONTROL OF EPIDEMIOLOGICAL STATUS OF HEPATITIS B POSITIVE CASES AMONG SHIRAZIAN BLOOD DONORS IN 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-051 A SURVEY OF EPIDEMIOLOGICAL STATUS OF HEPATITIS C INFECTION AMONG SHIRAZIAN BLOOD DONORS IN 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-052 RISK BEHAVIOUR AND MOTIVATION OF HEPATITIS C CASES IN BLOOD DONORS DURING 2005 |
| L. Kasraian, A. Torab Jahromi, B. Farahangiz (IBTO Research Center, Shiraz, Iran) |
| P-053 EVALUATION OF THREE AUTOMATED ANALYZERS FOR VIRAL SCREENING TESTS IN BLOOD DONORS |
| M.J. Kim, D.H. Seo, K.N. Lee, H.R. Chung, D.J. Oh, Q. Park, N.S. Cho, Y.J. Cha, B.M. Shin (Korean Red Cross, Seoul, South-Korea) |
| P-054 REACTIVATION OF HEPATITIS B VIRUS (HBV) IN A MULTITRANSFUSED PATIENT - CONFIRMATION BY LOOK-BACK STUDY USING STORED SPECIMENS |
| S Kino, Y. Tomoda, R. Endo, K. Shibusa, K. Ikuta, K. Sato, Y. Kogo, K. Morishita, S. Sato, T. Kato, H. Ikeda (Asahikawa Medical College Hospital, Asahikawa, Japan) |
| P-055 CONFIRMATION FOR DISCOVERED HCV-AB TO VOLUNTEER DONORS IN THE DEPARTMENT FOR TRANSFUSION IN TETOVO DURING 2005 BY USING PCR TECHNIQUE |
| E. Kocovska, S. Kostovska, T.T. Timova (Tetovo Hospital, Tetovo, Macedonia) |
| P-056 PREVALENCE OF ANTI-HBC ANTIBODIES IN BLOOD DONORS IN THE SOUTH REGION OF POLAND |
| J. Kusmierczyk, J. Zatorska, J. Ras, A.S. Swierk, A. Glista, Z.B. Banach, A.G. Gasiorkiewicz, A.K. Kolbusz (Regional Blood Centre, Cracow, Poland) |
| P-057 OCCURRENCE OF HBSAG MUTANTS IN TWO KOREAN BLOOD DONORS |
| S.Y. Kwon, K.W. Youn, O.J. Kwon, S.W. Ryu, E.J. Kim, U.S. Joung, M.W. Hwang, D.H. Seo, N.S. Cho (Korean Red Cross, Seoul, South-Korea) |
| P-058 HEPATITIS B VIRUS GENOTYPES AND SURFACE ANTIGEN VARIANTS IN FRENCH BLOOD DONORS |
| S. Laperche, A. Sevant-Delmas, F. Bouchardeau, A. Girault, M. Mercier, F. Wind, M.H. Elghouzzi (INTS, Paris, France) |
| P-059 HEPATITIS C VIRAL INFECTION AMONG BLOOD DONORS - ROUTE OF TRANSMISION |
| I. Libek, D. Mijovic Nikolic (Clinical Hospital Zemun, Belgrade, Serbia and Montenegro) |
| P-060 SEROPREVALENCE OF VIRAL HEPATITIS A IN BLOOD DONORS IN MARIBOR |
| B.M.V. Majcen Vivod, V.U.S. Urlep Salinovic, L. Lokar, B.B. Bizjak, I.M. Maracic (Maribor Teaching Hospital, Maribor, Slovenia) |
| P-061 HEPATITIS B AND MOLECULAR SCREENING ASSAYS: EVIDENCE FOR DIFFERENT OUTCOMES OF THIS INFECTION |
| M. Miceli, P. Iudicone, G. Isacchi, A. Agresti, M. Palange, A. Di Lorenzo, E. Mannella (Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy) |
| P-062 LOW RATE OF OCCULT HEPATITIS B VIRUS INFECTION AMONG ANTI-HBC POSITIVE BLOOD DONORS IN YOUNG VOLUNTEER DONORS OF KOREA |
| H.K. Min, C. Ihm, Y.G. Kim (Medical & Quality Management Office, Dae, Taejeon, South-Korea) |
| P-063 INCREASED RISK OF HEPATITIS IN TAIWANESE MALE CONSCRIPTEES WITH TATTOOS |
| D.E.R. Ming-der (Yung-Kang Veterans Hospital, Yuan-kang City, Tainan, Taiwan) |
| P-064 EVOLUTION OF HCV GENOTYPES IN LISBON REGIONAL BLOOD CENTER |
| M.I. Neves, J. Pereira, F. Ferreira, G. Sousa (Instituto Português do Sangue/CRSL, Lisboa, Portugal) |
| P-065 THE PREVALENCE OF HEPATITIS MARKERS AMONG THE PATIENTS WITH ALL |
| T. Nurka, R. Çina, G. Kuli, S. Lako, V. Kardhashi (National Blood Transfusion Service, Tirana, Albania) |
| P-066 PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG) SEROPOSITIVITY IN SICKLE CELL ANAEMIA PATIENTS IN BENIN CITY |
| E.C. Okocha, O.A. Ejele (Nnamdi Azikiwe University, Nnewi, Nigeria) |
| P-067 SEROLOGICAL MARKERS FOR HBV INFECTION IN PORTUGUESE BLOOD DONORS |
| M. Queiros, C. Carvalho, S. Neto, J. Leal, P Mota, C. Moreira, C. Castro (IPS Centro Regional do Porto, Porto, Portugal) |
| P-068 EVALUATION OF THE COBAS TAQSCREEN MPX TEST FOR THE SIMULTANEOUS DETECTION OF HCV, HBV, HIV-1 GROUP M, HIV-1 GROUP O AND HIV-2. EXPERIENCE OF THE PORTO REGIONAL BLOOD CENTRE |
| L. Queiros, A. Tender, A. Aguiar, J. Azevedo (Centro Regional de Sangue do Porto, Porto,Portugal) |
| P-069 THE IMPORTANCE OF NEOPTERIN TESTING FOR DIAGNOSTICS |
| A. Ragimov, N. Dashkova, N. Nikishova (National Research Center of Surgery, Moscow, Russian Federation) |
| P-070 ANTI-HBC TESTING OF BLOOD DONORS IN INDIA - VALUE AND FOLLOW-UP STRATEGIES TO IMPROVE BLOOD SAFETY WITH MINIMUM LOSSES |
| H. Ranganathan, J. Diment, K. Kulathu, N. Iyer (Global Hospital, Hyderabad, India) |
| P-071 HCV INFECTION IN MULTI-TRANSFUSED AND PUTATIVE IMMUNO-COMPROMISED PATIENTS IN ARGENTINA |
| M.C.R. Remesar, C. Gamba, S. Oknaian, M. Batalla, A.E. Del Pozo (Hospital de Pediatria Garrahan, Buenos Aires, Argentina) |
| P-072 EVALUATION OF A NEW HCV COMBINATION ASSAY IN THE TAIWANESE BLOOD DONOR POPULATION |
| C. Rodgers, K.T. Lin, Y.W. Wu, Y.J. Lee, J.W. Chen, K.C. Lin (Abbott Laboratories, Dartford,United Kingdom) |
| P-073 EVALUATION AND ONE-YEAR EXPERIENCE USING HCV NAT BASED ON NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION FOR SCREENING BLOOD DONATIONS IN ARGENTINA |
| E. Rodriguez, A. Guichón, M.E. Acevedo, L. Tomasone, R.J. Fernández (Fundación Hemocentro Buenos Aires, Buenos Aires, Argentina) |
| P-074 MOLECULAR EPIDEMIOLOGY OF HCV IN PORTUGAL |
| S.S. Sargento, A.M. Almeida, C. Ferreira, E. Silva, P. Neto, C. Colaborators (Hospitais da Universidade de Coimbra, Coimbra, Portugal) |
| P-075 SEROLOGICAL AND MOLECULAR MARKERS OF HEPATITIS B VIRUS IN SPANISH BLOOD DONORS: EVIDENCE OF OCCULT HEPATITIS B |
| S. Sauleda, R.M. Maymo, M. Piron, D. Candotti, J.P. Allain, J.M. Hernandez, L.l. Puig, N. Casamitjana (Banc de Sang i Teixits, Barcelona, Spain) |
| P-076 EPIDEMIOLOGY OF HIV, HCV AND HBV INFECTIONS IN ABOUT 1.4 MILLION VOLUNTARY, NON-REMUNERATED BLOOD DONATIONS OF THE GERMAN RED CROSS BLOOD DONOR SERVICE BADEN-WUERTTEMBERGHESSEN IN THE YEAR 2005. |
| E. Schellenberg, S. Findhammer, K. Frank, K. Gubbe, A. Karl, G. Geusendam, A. Vosberg, T. Dengler, U. Mayr-Wohlfahrt, M. Loehr, E. Gruenelt, M. Schmidt, W. Sireis, E. Seifried (Red Cross Blood Donor Service Ba-Wue-He, Frankfurt am Main, Germany) |
| P-077 ANTI-HBC SCREENING OF BLOOD DONORS - A COMPARISON OF SEVEN ANTI-HBC SCREENING ASSAYS |
| M.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl, M. Loehr, E. Gruenelt, W. Sireis, W.K. Roth, E. Seifried, G. Geusendam (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-078 IMPLEMENTATION OF ANTI-HBC-TESTING INTO BLOOD DONOR SCREENING IN GERMANY |
| M.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl, M. Loehr, E. Gruenelt, W. Sireis, E. Seifried, G. Geusendam (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-079 PREVALENCE OF ANTI-HBC ANTIBODIES IN SWISS BLOOD DONORS, A 4 MONTH SURVEY AT THE BLOOD TRANSFUSION CENTER BASEL |
| C. Stebler, L. Infanti, B. Eiche, M. Santoro, C. Doepfner, T. Rüefli, M. Rüesch (Blood Transfusion Center Basel, Basel, Switzerland) |
| P-080 TRANSFUSION OF BLOOD FROM TWO DANISH BLOOD DONORS INFECTED WITH HEPATITIS B VIRUS ESCAPE MUTANTS – DIFFERENT OUTCOME IN 10 RECIPIENTS |
| H. Ullum, L. Harritshøj, U. Wend, P. Platz, H. Ring-Larsen, E. Dickmeiss, W.G. Wolfram (Rigshospitalet, Copenhagen, Denmark) |
| P-081 HCV GENOTYPE DISTRIBUTION AMONG NORTHEAST-THAI BLOOD DONORS |
| Y. Urwijitaroon, C. Sengthong, S. Barusrux (Fac.Associated Medical Sciences, Khon Kaen, Thailand) |
| P-082 HBV DNA DETECTION IN HBSAG NEGATIVE/ANTI-CORE POSITIVE ITALIAN FIRST TIME BLOOD DONORS |
| C. Velati, L. Romanò, L. Fomiatti, G. Cambiè, A. Zanetti (Dipartimento di Medicina Trasfusionale, Sondrio, Italy) |
| P-083 TRANSFUSION-TRANSMITTED DISEASES AND THEIR FREQUENCY CHANGE BY THE YEARS IN BLOOD DONORS OF A HOSPITAL BLOOD BANK IN GREECE |
| K. Ziciadis, F. Karabini, E. Xanthi, A. Tzolou, E. Chrisostomou, E. Zervou (University Hospital of Ioannina, Ioannina, Greece) |
| P-084 THE STRATEGY FOR ELIMINATING HBV. TRANSMISSION THROUGH BLOOD TRANSFUSION IN UNITED ARAB EMIRATES |
| A.H.A. Al Amiri (Ministry of Health, Sharjah, United Arab Emirates) |
| P-085 EVIDENCE ON ANTI-HBc REACTIVITY AMONG GREEK BLOOD DONORS AND CORRELATION BETWEEN ANTI-HBc TITRE AND THE PRESENCE OF HBV DNA |
| A. Varaklioti, I. Kalfa, A. Kapsalis, A. Kouramba, P. Kotsi, A. Karafoulidou (2nd Blood Transfusion Center, Athens, Greece) |
| TOPIC 01.3 |
| Topic 01.3 |
| Blood Safety - TTD - TSEs |
| P-086 HIGH RATE OF VCJD TRANSMISSION IN MICE BY INTRAVENOUS INOCULATION OF WHOLE BLOOD |
| L. Cervenakova, O. Yakovleva, C. McKenzie (J.H.Holland Laboratory, ARC, Rockville, United States of America) |
| P-087 PERFORMANCE CHARACTERISTICS OF PALL’S ENHANCED LEUKOTRAP AFFINITY PRION REDUCTION FILTER |
| O. Coker, F. Andrade, S. Pesci, T. Budziak, F. Madraswalla, J. Peterson, B. Selman, G. DelGiacco (Pall Corporation, Port Washington, United States of America) |
| P-088 CREUTZFELDT-JAKOB DISEASE LOOK-BACK STUDY: AN UPDATE |
| K.A. Dorsey, S. Zou, E.P. Notari, C.T. Fang, R.Y. Dodd, L.B. Schonberger (American Red Cross, Rockville, United States of America) |
| P-089 ABILITY OF THE MACOPHARMA PRION CAPTURE (P-CAPTTM) FILTER TO REMOVE BRAIN PRPRES IN LEUKOREDUCED HUMAN RBC |
| L.G. Gregori, B. Lambert, R. Rohwer (VA Medical Center, Baltimore, United States of America) |
| P-090 IN VITRO EVALUATION OF RED CELL CONCENTRATES AFTER FILTRATION OVER THE NEW COMPOSAFE PR SYSTEM (SYSTEM FOR PRION REDUCTION FROM LEUKOCYTE DEPLETED RCC) |
| D. de Korte, R. Vlaar, C.W.N. Gouwerok, M. Kleine, S. Borghi, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-091 DETECTION OF INFECTIOUS PRION IN BLOOD BY PROTEIN MISFOLDING CYCLIC AMPLIFICATION TECHNOLOGY (PMCA) |
| F. Leon, C. Segarra, J. Coste (Etablissement Français du Sang, Montpellier, France) |
| P-092 REMOVAL OF THE ENDOGENOUS TSE INFECTIVITY PRESENT IN BLOOD USING PRDT TSE AFFINITY LIGANDS AND INTEGRATION OF THE LIGANDS INTO THE MACOPHARMA P-CAPT(TM) FILTER |
| G. Rohwer, L. Gregori, P. Gurgel, J. Lathrop, P. Edwardson, B. Lambert, R.G. Carbonell, S.J.B. Burton, D.J.H. Hammond (VA Maryland Health Care System, Baltimore, United States of America) |
| P-093 WHAT DIFFERENCE IN PRION PROTEIN EXPRESSION AND PROCESSING IN HUMAN BLOOD CELLS BETWEEN METHIONINE HOMOZYGOUS AND VALINE DONORS AT CODON 129 OF THE PRNP GENE |
| C. Segarra, S. Lehmann, J. Coste (Etablissement Français du Sang, Montpellier, France) |
| TOPIC 01.4 |
| Topic 01.4. |
| Blood Safety - TTD - West Nile Virus |
| P-094 WEST NILE VIRUS (WNV) AND DENGUE VIRUS (DV) ARE LOW RISK FOR TRANSFUSION IN GHANA |
| J.P. Allain, C. Li, K. Danso, E. Addo-Yobo, S. Owusu-Ofori (University of Cambridge, Cambridge, United Kingdom) |
| P-095 MONITORING OF GENETIC VARIABILITY OF WEST NILE VIRUS IN BLOOD DONOR SPECIMENS USING A MICROARRAY-BASED ASSAY |
| M. Rios, A. Grinev, S. Daniel, M. Laassri, V. Chizhikov, K. Chumakov, I.K. Hewlett (CBER/FDA, Bethesda, United States of America) |
| TOPIC 01.5 |
| Topic 01.5. |
| Blood Safety - TTD - Emerging Pathogens |
| P-100 IMMUNOGLOBULIN G ANTIBODIES AGAINST ENVIRONMENTAL MOULDS IN A NORWEGIAN HEALTHY POPULATION SHOWS A BIMODAL DISTRIBUTION FOR ASPERGILLUS VERSICOLOR |
| G. Hetland, B. Rydjord, V. Svenningsen, H.G. Wiker (Ulleval University Hospital, Oslo, Norway) |
| P-101 THE NEEDS OF LOOK BACK ON SCREENING OF HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 1 AND 11 (HTLV I / II) AMONG BLOOD DONORS IN SAUDI ARABIA |
| S. ibrahim Hindawi, G.A. Damanhouri, I.S. Kawashti, I. Felemban, M. Alshawa, M. Khanbashi (KAUH, Jeddah, Saudi Arabia) |
| P-102 TRANSFUSION-TRANSMITTED HUMAN PARVOVIRUS B19 INFECTION IN A THALASSAEMIA PATIENTS |
| M. Mahmoodian Shooshtari, M. Nabi Foroghi, Z. Sharifi (Research Center of IBTO, Tehran, Iran) |
| P-103 IN VITRO EVALUATION OF CELL-MEDIATED IMMUNITY TO EPSTEIN BARR VIRUS |
| M. Mahmoodian Shooshtari, M. Bani Talebi Dehkordi, Z. Sharifi (Research Center of IBTO, Tehran, Iran) |
| P-104 INACTIVATION OF CHIKUNGUNYA VIRUS IN PLASMA AND PLATELETS USING HELINX TECHNOLOGY, AS UTILIZED IN THE INTERCEPT BLOOD SYSTEM |
| L. Corash, L. Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham, K. Tsetsarkin, S. Higgs (Cerus Corporation, Concord, United States of America) |
| TOPIC 01.6 |
| Topic 01.6. |
| Blood Safety - TTD - Nucleic Acid Amplification Technology (NAT) |
| P-105 THE CONTRIBUTION OF NUCLEID ACID TESTING (NAT) IN BLOOD TRANSFUSION SAFETY. DETECTION OF FOUR NAT HBV DNA POSITIVE, HBS AG NEGATIVE IN SINGLE BLOOD DONATIONS |
| C. Politi, V. Dimitra, L. Kavallierou, V. Triantaltillou, (G.Gennimatas Hospital, Athens, Greece) |
| P-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX HIV/HBV/HCV NAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNIT IN KUMASI, GHANA |
| J.P. Allain, S. Owusu-Ofori, G. Bedu-Addo, D. Candotti, A. Nsiah-Asare, F. Sarkodie (University of Cambridge, Cambridge, United Kingdom) |
| P-107 PREVALENCE OF HCV AND HGV INFECTION AMONG THALASSEMICS, HEMOPHILICS, AND HEMODIALYSIS PATIENTS WITH CHRONIC HEPATITIS |
| S. Amini Kafi-abad, A. Talebian, S. Samiee, F. Ranjbar Kermani, M.M. Moghtadaie, F. Ferdowsian, N.P. Pasandideh, Z. Ataie, M. Kavari, A. Gharehbaghian (Research Center of Iranian Blood Transfusion, Tehran, Iran) |
| P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED NAT SYSTEMS CHIRON PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201 |
| A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux, I. Dupont, P. Gallian, C. Guitton, P. Morel, G. Andreu (EFS Centre Atlantique, Tours, France) |
| P-109 WINDOW PERIOD OF HIV INFECTION IN A REPEAT BLOOD DONOR |
| L. Barea, R. Gonzalez, J.l. Bueno, L. Muñoz, A. Garcia, E. Castro (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF HBV DNA POSITIVE/ HBSAG NEGATIVE BLOOD DONORS |
| E. Brojer, M. Letowska, G. Liszewski, P. Grabarczyk, M. Mikulska (Institute of Haematology and Blood Transfusion, Warsaw, Poland) |
| P-111 HIGH THROUGH-PUT, INDIVIDUAL DONOR TESTING (IDT) USING THE PROCLEIX TIGRIS SYSTEM: A 5-MONTH EXPERIENCE |
| R. Cable (Western Province Blood Transfusion Servi, Cape Town, South Africa) |
| P-112 INTERPRETATION OF HBV NAT RESULTS IN HEALTHY SUBJECTS |
| G. Cambie, A. Degiuli, S. Conca, E. Parabiaghi, L. Vignati, M.L. Nardella, M. D'Agostino, F. D'Agostino (Azienda Ospedaliera di Lodi, Lodi, Italy) |
| P-113 ACUTE PHASE AND OCCULT HBV INFECTIONS WITH MULTIPLE MUTATIONS IN THE SURFACE ANTIGEN “A” DETERMINANT DETECTED BY HBV/HCV/HIV-1 TMA SCREENING OF SPANISH BLOOD DONORS |
| E. Castro, P. Torres, R. González, A. Ontañón, L. González Ponte, M. Sedeño, J.M. Echevarría, M. Koppelman, H. Zaaijer, J.M. Hernández, N. Lelie (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-114 ANALYTICAL PERFORMANCE OF PROCLEIX DUPLEX AND TRIPLEX TMA ASSAYS IN AN HISTORICAL PROFICIENCY PROGRAMME |
| A. van Drimmelen, P.N. Lelie, D. Jardine (AcroMetrix Europe, Alkmaar, Netherlands) |
| P-115 REAL- TIME PCR ASSAY BY LIGHT CYCLER FOR THE DETECTION OF PLASMODIUM SPECIES |
| S. Dupont, A. Berry, J.M. Fondere, C. Segarra, C. Maugard, T. Levayer (EFS Pyrénées Mediterranée, Montpellier, France) |
| P-116 AN HCV SEROCONVERSION DETECTED USING A NAT TEST PROCEDURE DURING SCREENIG OF BLOOD AND BLOOD COMPONENTS IN A DONOR POPULATION IN ITALIAN CAMPANIA REGION |
| C. de Felice, C. de Felice, F. Morelli, A. Miscioscia, D. Ametrano, C. Fasulo, S. Guardascione, M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy) |
| P-117 INDIVIDUAL HEPATITIS B VIRUS NUCLEIC ACID TESTING (HBV-NAT) ON 61.825 BLOOD DONATIONS IN MADRID, SPAIN |
| R. Gonzalez, J.M. Echevarría, A. Avellon, L. Barea, J.L. Bueno, E. Castro (Centro de Transfusión Cruz Roja Española, Madrid, Spain) |
| P-118 EVALUATION OF SINGLE NAT IN A NATIONAL BLOOD SERVICE |
| A. Gottreich, B. Cohen, L. Shvartz, V. Arad, O. Frenkel, V.B. Yahalom, E. Shinar (Magen David Adom, Tel-hasomer, Israel) |
| P-119 PERFORMANCE CHARACTERISTICS OF A NEW MULTIPLEX NAT SCREENING TEST FOR HBV, HCV AND HIV: THE COBAS TAQSCREEN MPX TEST ON THE COBAS S 201 SYSTEM |
| S. Herman, Y. Ohhashi, E. Kyger, H. Halait, M. Wiedmann, M. Zauke, L. Pietrelli (Roche Molecular Systems, Inc., Pleasanton, United States of America) |
| P-120 EXPERIENCE OF A LARGE GERMAN RED CROSS BLOOD DONOR SERVICE WITH NAT-TESTING: RESULTS OF SCREENING MORE THAN 9 MILLION BLOOD DONATIONS FOR HIV-1, HCV AND HBV |
| M.K. Hourfar, W.K. Roth, A. Themann, K. Gubbe, U. Mayr-Wohlfart, E. Seifried, M. Schmidt (German Red Cross, Institute Frankfurt, Frankfurt, Germany) |
| P-121 SIMULTANEOUS SCREENING FOR HCV, HIV-1 AND HBV IN BLOOD DONATIONS WITH THE FULLY AUTOMATED SYSTEM |
| P. Iudicone, M. Miceli, A. Agresti, M. Palange, A. Di Lorenzo, S. Berardini, C. Amedeo, A. Tudisco, R. Colaceci, E. Mannella (A.O. S.Camillo-Forlanini, Rome, Italy) |
| P-122 QUALITY CONTROL PROGRAMME FOR NUCLEIC ACID SCREENING IN BLOOD SERVICE LABORATORIES |
| K. Jardine, B.R.J. Dent, T. Pham, W. Dimech, E.M. Dax (National Serology Reference Laboratory, Fitzroy, Australia) |
| P-123 EVALUATION OF THE COBAS TAQSCREEN MULTIPLEX TEST AND S201 AUTOMATED NAT PLATFORM IN THE SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE. |
| L. Jarvis, A. Cleland, T. Dunsford, K. Mulligan, J. Petrik (SNBTS, Edinburgh, United Kingdom) |
| P-124 HBV AND HCV INFECTED BLOOD DONATIONS INTERDICTED BY INDIVIDUAL DONATION NUCLEIC ACID TESTING (ID-NAT) IN LITHUANIA |
| V. Kalibatas, J. Irzikeviciene, N. Lelie (National Blood Centre, Vilnius, Lithuania) |
| P-125 ANALYTICAL AND CLINICAL PERFORMANCE OF THE PROCLEIX ULTRIO HIV-1/HCV/HBV ASSAY IN LOW VIRAL LOAD SAMPLES |
| A. Katsoulidou, Z. Moschidis, V. Sypsa, M. Chini, G. Papatheodoridis, N. Tassopoulos, K. Mimidis, A. Karafoulidou, A. Hatzakis (Athens University Medical School, Athens, Greece) |
| P-126 THE IMPORTANCE OF IMPLEMENTING THE HBV DNA SCREENING USING NAT TESTING FOR TRANSFUSIONAL VALIDATION IN A HIGH HBV RISK AREA |
| M. Manca, A. Spano, R. Occhineri, F. Fadda, P. Manchia, F. Lumbau, P. Murgia, G. Tala, G. Sanna, G. Cossu (AUSL 1 - Sassari, Sassari, Italy) |
| P-127 HCV, HIV-1, HBV MOLECULAR SCREENING FOR BLOOD DONATION: FROM SEMI-AUTOMATE SYSTEMS TO THE FULLY AUTOMATED INSTRUMENT PLATFORM |
| E. Mannella, P. Iudicone, M. Palange, A. Agresti, R. Colaceci, A. Tudisco, C. Amedeo, S. Berardini, M. Miceli (Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy) |
| P-128 COMPARISON OF THE CHIRON PROCLEIX® TIGRIS® AND ROCHE COBAS S 201 NUCLEIC ACID TESTING (NAT) SYSTEMS FOR SIMULTANEOUS DETECTION OF HIV/HCV RNA AND HBV DNA |
| A.R. Margaritis, S. Brown, C.R. Seed, P. Kiely, B. D'Agostino, C.K. Lin, A.J. Keller (Australian Red Cross Blood Service, Perth, Australia) |
| P-129 BENEFITS OF THE TEST CHIRON PROCLEIX ULTRIO ASSAY HCV/HIV/HBB IN THE IMPROVEMENT OF BLOOD SAFETY |
| F. Morelli, C. de Felice, M.M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy) |
| P-130 AUTOMATED HANDLING OF LARGE POOLS FOR MULTIPLEX NAT SCREENING OF HCV, HIV-1 (GROUPS M & O), HIV-2, AND HBV ON THE COBAS S 201 SYSTEM |
| J. Nunes, H. Rothe, C. Parkhouse, I. Trefil, J. Weinberger, G. Velasco-Corpuz, J. Sopher (Roche Molecular Systems, Pleasanton, United States of America) |
| P-131 HCV, HIV, HBV GENOME DETECTION IN BLOOD DONORS WITH THE USE OF A NEW MOLECULAR ASSAY |
| E. Perna, M. D'Onofrio, L. Paesano, G. Ciardiello, E. D'Agostino, S. Formisano (AOU Federico II, Naples, Italy) |
| P-132 HBV DNA TESTING IN BLOOD DONORS REACTIVE FOR ANTI HBC ANTIBODY - A PILOT STUDY FROM SOUTH INDIA |
| H. Ranganathan, N. Iyer, D. Saranath, K. Kulathu (Global Hospital, Hyderabad, India) |
| P-133 PREVALENCE OF CMV-DNA IN IRANIAN HEALTHY BLOOD DONORS |
| F. Ranjbar Kermani, S. Amini, A. Talebian, S. Samiei, F. Ferdowsian, M. Sobhani (Iranian Blood Transfusion Research Center, Tehran, Iran) |
| P-134 EARLY EXPERIENCE WITH INDIVIDUAL DONATION HBV/HCV/HIV-1 NUCLEIC ACID AMPLIFICATION TESTING (ID-NAT) IN THE SOUTH AFRICAN NATIONAL BL0OD SERVICE |
| W. Sykes, M. Vermeulen, A. Neill, E. Kuun, N. Lelie, J. Mitchell, L. Pillay, R. Reddy (South African National Blood Service, Pinetown, South Africa) |
| P-135 NAT SCREENING FOR HIV/HCV (PROCLEIX, CHIRON) IN SINGLE DONATION IN COIMBRA, PORTUGAL (2000-2006) |
| J.N. Teixeira, F. Henggeler, R. Diniz, B. Caldeira, N. Mateus, H. Gonçalves (Portuguese Blood Institute, Coimbra, Portugal) |
| P-136 EVALUATION OF ACCEPTED BLOOD DONORS WITH A MULTIPLEX NUCLEIC ACID TEST (NAT)AT CHIANG MAI UNIVERSITY HOSPITAL, THAILAND |
| L.T. Thaikruea, N.N. Niwes, S.T. Thongsawat, L.N. Litrakoon, L.F. Fonksatidkil, P.S. Sompan, A.H. Heaton, D.N. Nichols, K.N. Nelson (Department of Community Medicine, Chiang Mai 50200, Thailand) |
| P-137 NAT SCREENING FOR HCV, HIV AND HBV ON BLOOD DONATIONS IN ITALY |
| C. Velati, L. Fomiatti, L. Romanò, L. Baruffi, A. Zanetti (Dipartimento di Medicina Trasfusionale, Sondrio, Italy) |
| P-138 ANALYTICAL PERFORMANCE CHARACTERISTICS OF THE PROCLEIX ULTRIO HIV-1/HCV/HBV ASSAY ON TIGRIS IN A LARGE SCALE EVALUATION OF INDIVIDUAL DONATION NAT IN SOUTH AFRICA |
| M. Vermeulen, W. Sykes, L. Gaggia, N. Lelie, R. Reddy, E. Kuun, A. Neil (South African National Blood Service (SANBS), Johannesburg, South Africa) |
| P-139 DETECTION OF BRUCELLA AMONG VOLUNTARY BLOOD DONORS IN TURKEY BY USING NEW REAL TIME PCR METHOD |
| T. Yavuz, D. Kaya (Duzce University Medical School, Duzce, Turkey) |
| P-140 DRUG RESISTANCE INHIBITION IN KEUKEMIC CELLS BY ANTISENSE OLIGONUCLEOTIDES |
| F. Nadali, A.A. Pourfatollah, K. Alimoghaddam (School of Medicine, Isfahan, Iran) |
| TOPIC 01.7 |
| Topic 01.7. |
| Blood Safety - TTD - Bacterial Contamination |
| P-141 ROUTINE BACTERIAL MONITORING OF PLATELETS AT THE WELSH BLOOD SERVICE |
| R. Ahya, G. Rowe, M. Hayward, S. Pearce, R. Jones (Welsh Blood Service, South Glamorgan, United Kingdom) |
| P-142 DETECTION OF MICROBIAL CONTAMINATION OF POOLED WHOLE BLOOD-DERIVED PLATELET-RICH PLASMA PLATELETS IN THE GREATEST BLOOD BANK ROUTINE OF LATIN AMERICA |
| G.A.O.B. Barna, R.K.F. Guillaume, C.R. Kamakura, S.R. Matana, M.V. Moço, P.C. Sierra, S.M. Winkaler, P.E. Dorlhiac-Llacer, D.A.F. Chamone (Pro-Sangue Sao Paulo Blood Center, Sao Paulo, Brazil) |
| P-143 BACTERIA RAPID DETECTION IN NON LEUCOCYTE REDUCED WHOLE BLOOD PLATELETS |
| I. Besson Faure, I. Besson Faure, A. Raimondo, A.E. Houlle Declomesnil (Hemosystem, Marseille, France) |
| P-144 AUTOMATION OF THE SCANSYSTEM™ PROCESS |
| I. Besson Faure, R. Chollet, A.E. Houlle Declomesnil (Hemosystem, Marseille, France) |
| P-145 PREVENTION OF TRANSFUSION-TRAMSMITTED BACTERIAL INFECTIONS |
| E.K. Klausa, B.M. Muzala - Bogdan, J.K. Korsak (Regional Centre
of Transfusion Medicine, Wroclaw, Poland) |
| P-146 COMPARISON OF TWO SYSTEMS (BACT/ALERT VS SCANSYSTEM) FOR ROUTINE BACTERIAL DETECTION IN T-SOL BUFFY COAT PLATELET CONCENTRATES |
| M. Lambermont, R. de Meuter, D. Sondag (Service du Sang, Belgian Red Cross, Brussels, Belgium) |
| P-147 VALUE OF ANAEROBIC CULTURE IN BACTERIAL SURVEILLANCE PROGRAMME FOR PLATELET CONCENTRATES |
| C. Lee, C.K. Lee, P.L. Ho, W.C. Tsoi, C.K. Lin (HK Red Cross Blood Transfusion Service, Hong Kong, China) |
| P-148 DETECTION OF BACTERIAL CONTAMINATION IN RED CELL UNITS USING THE PALL ENHANCED BACTERIAL DETECTION SYSTEM |
| C.P. McDonald, K. Goodhand, K. Wilkins, J. Colvin (National Blood Service, London, United Kingdom) |
| P-149 ARE THE BACT/ALERT AND PALL ENHANCED BACTERIAL DETECTION SYSTEMS SUITABLE FOR SCREENING PLATELET ADDITIVE SOLUTION (PAS) PLATELET CONCENTRATES? |
| C.P. McDonald, J. Sapsford, J. Colvin, C. Biggs, K. Goodhand (National Blood Service, London, United Kingdom) |
| P-150 EVALUATION AND ROUTINE PERFORMANCE OF A "BEST PRACTICE" DONOR ARM DISINFECTION PROCEDURE: CHLORAPREP® |
| C.P. McDonald, C. Biggs, B. Lees, N. Beckman, J. Kellington, G. Evans (National Blood Service, London, United Kingdom) |
| P-151 BACTERIAL CONTAMINATION OF BLOOD COMPONENTS |
| S.M. Milosavljevic, A.M. Andjelic, N.N. Nedeljkovic, V.P. Poprzen, D.V. Vidanovic (National Blood Transfusion Institute, Belgrade, Serbia and Montenegro) |
| P-152 PLATELET BACTERIA SCREENING - HOW TO APPLY THE DIFFERENT APPROACHES? |
| Th. Montag-Lessing (Paul Ehrlich Institute, Langen, Germany) |
| P-153 REDUCTION OF BACTERIAL LOAD DURING PREPARATION OF POOLED PLATELET CONCENTRATES FROM BUFFY COATS EXPLAINS A SIMILAR CONTAMINATION RATE AS IN APHERESIS PLATELETS |
| H. Müller, A. Bayer, H. Mohr (DRK-Blutspendedienst NSTOB, Springe, Germany) |
| P-154 GROWTH PROPERTIES OF DIFFERENT BACTERIA STRAINS IN PLATELET CONCENTRATES AND CONSEQUENCES FOR THE APPLICATION OF SCREENING METHODS |
| S.B. Nicol, M. Schmidt, J. Brachert, Th. Montag (Paul Ehrlich Institut, Langen, Germany) |
| P-155 DETECTION OF BACTERIAL CONTAMINATION IN PLATELET CONCENTRATES: A REAL TIME DNA POLYMERASE CHAIN REACTION TEST IS FEASIBLE BEFORE TRANSFUSION |
| P. Pagliaro, C. Glingani (Ospedale Carlo Poma, Mantova, Italy) |
| P-156 DEVELOPMENT OF A REAL-TIME POLYMERASE CHAIN REACTION FOR THE DETECTION OF GRAM-POSITIVE BACTERIA IN PLATELET CONCENTRATES |
| M. Piron, N. Casamitjana, M. Bes, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain) |
| P-157 EVALUATION OF THE CORRECT USE OF VIRKON DISINFECTANT IN REDUCING BACTERIAL CONTAMINATION OF PLATELETS COMPONENTS PREPARED IN TEHRAN BLOOD CENTER WITHIN SECOND HALF OF 2005 |
| M Sadeh (Islamic Azaad University, Tehran, Iran) |
| P-158 NOVEL APPLICATION WITH QUENCHING DYE IMPROVES OPTIMIZED SCANSYSTEMTM FOR RAPID BACTERIAL DETECTION |
| M.S. Schmidt, A. Themann, S.-B Nicol, T. Montag, W.K. Roth, E. Seifried, M.K. Hourfar (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| P-159 DEATH AFTER TRANSFUSION OF PLATELET CONCENTRATE CONTAMINATED WITH KLEBSIELLA PNEUMONIAE |
| M.S. Schmidt, S.-B Nicol, M.K. Hourfar, W. Sireis, W. Weichert, E. Seifried, T. Montag (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| TOPIC 01.8 |
| Topic 01.8. |
| Blood Safety - TTD - Parasites and Protozoa |
| P-160 IMPLEMENTATION OF CHAGAS DISEASE SCREENING IN FRENCH BLOOD DONORS |
| A. Assal, C. Cornillot, N. Baudoncourt, O. Garraud, G. Andreu (EFS Centre Atlantique, Tours, France) |
| P-161 CORRELATION BETWEEN THE SPECIFIC SERUM IMMUNOGLUBULINES ( IGE,IGG) WITH EOSINOPHILIA IN CYSTIC HYDATIDOSIS PATIENTS |
| Z. Ghayour (School of Medicine, Isfahan, Iran) |
| P-162 PREVALENCE OF TRYPANOSOMA CRUZI INFECTION AFTER SCREENING OF BLOOD DONORS AT RISK IN NORTHEAST SPAIN |
| M. Piron, R.M. Maymo, J.M. Hernandez, M. Verges, M. Portus, R. Fisas, N. Casamitjana, J. Munoz, J. Gascon, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain) |
| P-163 EFFICACY OF THE LEUKOREDUCTION TO REDUCE THE RISK OF LEISHMANIA INFANTUM TRANSFUSION TRANSMISSION. STUDY IN BLOOD DONORS FROM THE MAJORCA ISLAND (BALEARIC ISLANDS, SPAIN) |
| C. Riera, P. Lopez-Chejade, R. Fisa, T. Serra, M. Sedeno, T.
Jimenez, E. Girona, M. Mascaro, J. Muncunill, M. Udina, A. Forteza, M. Gallego, J. Carrio, M. Portus (Universitat de Barcelona/Facultad de Far, Barcelona, Spain) |
| P-164 SERO - EPIDEMIOLOGICAL STUDY OF CHAGAS’ DISEASE AND SYPHILIS IN THE CENTENNIAL PROVINCIAL HOSPITAL ROSARIO ARGENTINA |
| P. Sciarratta, M.A. Operto, J. Valverde (Fac. Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina) |
| P-165 EVALUATION OF THE ARCHITECT SYPHILIS TP ASSAY IN A SWISS BLOOD BANK- A PROSPECTIVE COMPARISON WITH THE SERODIA TPPA ASSAY |
| C. Stebler, L. Infanti, M. Santoro, T. Rüefli, C. Doepfner, M. Rüesch (Blood Transfusion Center Basel, Basel, Switzerland) |
| P-166 MEASUREMENT OF P. VIVAX PARASITEMIA. |
| I.B. Suh, S.W. Ryu, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee (Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea) |
| TOPIC 02.1 |
| Topic 02.1. |
| Red Cells - Immunohaematology |
| P-168 DIFFICULTIES IN THE DETECTION OF KIDD ANTIBODIES |
| S. Adam, V. Kretschmer (Institut of Transfusion Medicine, Marburg, Germany) |
| P-169 AN ACUTE HAEMOLYTIC TRANSFUSION REACTION (AHTR) DUE TO AN UNDETECTABLE ANTI-JKA |
| S. Adam, G. Bringmann, M. Bieringer, H.J. Heyers, V. Kretschmer (Institut of Transfusion Medicine, Marburg, Germany) |
| P-170 FLOW CYTOMETRY AND PANEL REACTIVE ANTIBODY METHODS FOR DETECTING ANTI-HLA CLASS-I ANTIBODIES |
| M. Aghaeipour (Iranian Blood Transfusion Research Cente, Tehran, Iran) |
| P-171 DETERMINATION OF A DISSOCIATION PARAMETER IN RED BLOOD CELLS AGGLUTINATED BY MONOCLONAL ANTIBODY ANTI-A USING A LASER BACKSCATTERING TECHNIQUE |
| L.V. Altube, P. Foresto, B. Riquelme, A. Marenzana, J. Valverde (UNR, Rosario, Argentina) |
| P-172 IL-8 & TNF-A LEVELS IN DUFFY NEGATIVE BLOOD DONORS |
| O.A. Asher, C. Pariente, H. Kanety, S. Gelman, E. Shinar, V. Yahalom (Blood Services Center, Magen David Adom, Ramat Gan, Israel) |
| P-173 FIRST FINDING OF GY(A-) PHENOTYPE IN THE CZECH REPUBLIC SINCE ITS DISCOVERY IN 1967. POSSIBLE RELATIONSHIP TO ORIGINAL PROBANDS FOUND IN THE USA IN 1967-1968 |
| H. Banzetova, D. Bystricka, O. Cerna, M. Pisacka, J. Poole, J. Svobodna, P. Trubac (Hospital of Ceske Budejovice, Ceske Budejovice, Czech Republic) |
| P-174 ABO BLOOD GROUP GENOTYPING IN CROATIAN BLOOD DONORS |
| J. Bingulac-Popovic, V. Drazic, J. Culej, I. Babic, Z. Hundric-Haspl, C. Maglov, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-175 ABO BLOOD GROUPS AND RISK OF THROMBOSIS |
| J. Bingulac-Popovic, V. Drazic, I. Babic, J. Culej, M. Tomicic, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-176 THE COMPUTER COSSMATCH: THE VALIDATION AND 1ST. IMPLEMENTATION IN CZECH REPUBLIC |
| M. Bohonek, D. Horcickova, M. Blazkova, T. Lejdar, P. Svenda (Central Military Hospital, Prague, Czech Republic) |
| P-177 UNEXPECTED RESULTS IN BLOOD GROUP SEROLOGY: THE CHALLENGE OF IMMUNOHAEMATOLOGICAL PUZZLING |
| A.G. van den Bos, B.D. Steetzel, C. Mouton, S. Kapteijns-van Kordelaar, V.M.J. Novotny (Radboud University Medical Center, Nijmegen, Netherlands) |
| P-178 ASSESSMENT OF IMMUNOLOGICAL PROPERTIES OF MIRASOL PATHOGEN REDUCTION TREATED RED BLOOD CELLS |
| K.A. Buytaert-Hoefen, H. Reddy, S. Doane, R. Goodrich (Navigant Biotechnologies, Lakewood, Colorado, United States of America) |
| P-179 EXPRESSION OF ABH ANTIGENS IN PATIENTS WITH PRECANCEROUS AND CANCEROUS ORAL LESIONS |
| C. Campi, S. García Borrás, L. Racca, A. Racca, C. Cotorruelo, C. Biondi (Universidad Nacional de Rosario, Rosario, Argentina) |
| P-180 HIGH-THROUGHPUT DNA ANALYSIS FOR RED BLOOD CELL ANTIGENS FACILITATES THE TRANSFUSION SUPPORT WITH ANTIGEN-MATCHED BLOOD IN POLYTRANSFUSED PATIENTS |
| L.C. Castilho, J. Pellegrino Jr, M. Mota, G. Hashmi, S. Shariff, M. Seul, F. Costa (Unicamp, Campinas, Brazil) |
| P-181 DNA ANALYSIS IN A MICROARRAY AS A SUBSTITUTE FOR DOMBROCK TYPING: A NOVEL ALLELE IN BRAZILIANS |
| L.C. Castilho, W. Baleotti Jr, K. Ribeiro, D.C. Credidio, G. Hashmi, M.E. Reid (Unicamp, Campinas, Brazil) |
| P-182 RHD GENOTYPING OF BLOOD DONORS MAY PREVENT ALLOIMMUNIZATION BY D ANTIGEN |
| L.C. Castilho, T. Paixao, C. Barros, D.C. Credidio, K. Ribeiro, F. Costa (Unicamp, Campinas, Brazil) |
| P-183 A NOVEL DO ALLELE COMBINATION NAMELY DOB-WL |
| L.C. Castilho, W. Baleotti Jr, M.E. Reid, M. Rios, J. Pellegrino Jr, A. Fabron Jr, F. Costa (Unicamp, Campinas, Brazil) |
| P-184 EVALUATION OF THE GALILEO AUTOMATED BLOOD BANK SYSTEM FOR WEAK D DETECTION ON BLOOD DONORS |
| M. Chabert, M.J. Rodrigues, C. Cordeiro, P. Fernandes, V. Paquete, M. Rodrigues, J. Pereira, P. Mendonca (Instituto Português do Sangue, Lisboa, Portugal) |
| P-185 THE VALUE OF ELUTION TEST USING GEL MICROCOLUMN AGGLUTINATION METHOD FOR ACID ELUATES |
| P. Chalkia, E. Kostopoulou, A. Tsoukala, V. Avgoloupi, P. Didoudi, S. Intzepeli, V. Bakaloudi, E. Ntinopoulou, H. Hassapopoulou, E. Hassapopoulou (Ahepa Hospital, Thessaloniki, Greece) |
| P-186 MOLECULAR GENETIC ANALYSIS AND FREQUENCY SURVEY OF H DEFICIENT PHENOTYPE IN FUJIAN POPULATION |
| Q. Chi, Y.J. Guo, W. Tang, Y. Chen, C.Q. Wang, G.L. Chen (Fujian Blood Center, Fuzhou, China) |
| P-187 PATERNAL RHD ZYGOSITY: SEROLOGY VERSUS GENETIC ANALYSIS |
| M. Christiansen, W. Kjellberg, O.B. Petersen, N. Grunnet (Aarhus University Hospital, Aarhus N, Denmark) |
| P-188 ACHIEVING REDUCED CYCLE TIMES FOR PRETRANSFUSION TESTING WITH TEST ORDER ENTRY MODIFICATIONS ON AUTOMATION |
| C. Colavecchia, A. Coovadia, S. South (Sunnybrook & Womens College HS Centre, Toronto, Canada) |
| P-189 MOLECULAR BACKGROUNDS FOR THE DCE (R0) HAPLOTYPE |
| C. Cotorruelo, G. Munini, S. García Borrás, L. Racca, R. Di Mónaco, C. Biondi, A. Racca (Universidad Nacional de Rosario, Rosario, Argentina) |
| P-190 ANALYSIS OF THE DEFORMABILITY OF ADHERED CELLS BY MEANS OF DIGITAL IMAGE PROCESSING |
| V. Danieli, A. D'Arrigo, D. Riquelme (Fac. Cs. Bioq. y Farm. - U.N.R., Rosario, Argentina) |
| P-191 FLEXIBILITY, SAFETY AND HIGH TROUGHPUT IN SAMPLING PROCESSUS OF BLOOD DONOR OR PATIENT SAMPLES FOR COMPLETE BLOOD GROUP SEROLOGY - EVALUATION OF A NEW AUTOMATE : HEMOS EVOLUTION (BIORAD) |
| M. Delamaire, S. Gaucheron, S. Flageul, G. Semana (Etablissement Français du Sang, Rennes, France) |
| P-192 HEREDITARY HEMOCHROMATOSIS: THE HAPTOGLOBIN 2-2 TYPE DISPLAYS A SIGNIFICANT BUT MODERATE INFLUENCE ON PHENOTYPIC EXPRESSION OF THE PREDOMINANT C282Y HOMOZYGOUS GENOTYPE |
| G. le Gac, C. Ka, V. Scotet, I. Gourlaouen, L. Bryckaert, C. Férec (EFS-Bretagne, INSERM U613, Brest, France) |
| P-193 K NULL PHENOTYPE CAUSED BY PREMATURE STOP CODON IN EXON 14 OF KEL GENE: A CASE REPORT. |
| A. Doescher, F. Wagner, E.K. Petershofen (German Red Cross Blood Transf.Service, Oldenburg, Germany) |
| P-194 MOLECULAR GENETIC RHCE CHARACTERIZATION OF 100 CASES WITH PROBLEMS IN AUTOMATED RH DETERMINATION. |
| A. Doescher, E.K. Petershofen, F. Wagner (German Red Cross Blood Transf.Service, Oldenburg, Germany) |
| P-195 PERFORMANCE EVALUATION STUDY OF A NOVEL LATERAL FLOW ASSAY FOR SIMULTANEOUS TYPING OF ABO, D, RHESUS SUBGROUPS AND K (“MDMULTICARD”) |
| C.G. Geisen, P. Schwind, E. Seifried (DRK Blood Donor Service, Frankfurt, Germany) |
| P-196 DIRECT ANTIGLOBULIN TEST (DAT) WITH A WALK AWAY INSTRUMENT AUTOVUE |
| L.W. Gustafsson (Karolinska, Stockholm, Sweden) |
| P-197 GYPB SILENCING IN AFRICAN AMERICANS BUT NOT IN CAUCASIANS |
| G. Hashmi, T. Shariff, Y. Zhang, K. Hue-Roye, D. Charles-Pierre, C. Lomas-Francis, M. Reid (Bioarrays Solutions, Warren, United States of America) |
| P-198 SEROLOGIC DIFFERENTIATION BETWEEN PARTIAL D AND WEAK D AND CORRELATION WITH RHESUS PHENOTYPES CCEE |
| E. Hassapopoulou, E. Kostopoulou, V. Bakaloudi, E. Ntinopoulou, P. Chalkia, P. Didoudi, V. Avgoloupi, S. Intzepeli, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece) |
| P-199 DBRBC- A NEW COLLABORATIVE RED BLOOD CELL BIOINFORMATICS RESOURCE |
| M. Helmberg, M. Feolo, D. Hoffman, R. Dunivin, O. Blumenfeld (Medical University Graz, Graz, Austria) |
| P-200 A NEW GENERATION OF ANTIBODY SCREENING TEST USING E.M. TECHNOLOGY ON A FULLY AUTOMATED SYSTEM AND A MANUAL WORKSTATION |
| F. Herbert, A. Boulet, D. Buns, A. Delanoe, P. Desmet, V. Godefroy, J.M. Pelosin, S. Petit, S. Sergent, O. Boulet, L. Fauconnier, S. Thorigny (Diagast, Loos, France) |
| P-201 ABO DISCREPANCIES AFTER INTENSIVE CHEMOTHERAPY FOR MALIGNANT DISEASES |
| T.I. Izumi, Y. Okada, K. Kashiwazaki, S. Tsunoda, H. Kobayashi, M. Akutsu, Y. Kano (Tochigi Cancer Center, Utsunomiya, Japan) |
| P-202 PERFORMANCE COMPARISON OF MEDION-MDMULTICARD, ID-DIAMED AND SCANGEL-BIORAD RHD/ABO SEROTYPING USING A MULTI-VARIANT, CAUCASIAN-SPECIFIC, GENOTYPED DONOR PANEL |
| C. Gassner, E. Rainer, E. Pircher, L. Markut, G. Kormoczi, C. Jungbauer, D. Wessin, R. Klinghofer, H. Schennach, P. Schwind, D. Schonitzer (Central Institute for Blood Transfusion, Innsbruck, Austria) |
| P-203 EVALUATION OF THE DIAGAST READY-TO-USE OLYMP RANGE FOR THE NEW ANALYSER OLYMPUS PK 7300 |
| L. Keyser, K. Keyser, C. Cordier, V. Godefroy, J.M. Pelosin, C. Gues, S. Simon, S. Thorigny (Diagast, Loos, France) |
| P-204 LINKAGE DISEQUILIBRIUM OF RHD 1227A AND IVS7+293T LEADING TO ABERRANT RNA SPLICING IN DEL INDIVIDUALS |
| H.L. Eng, T.M. Lin, Y.F. Yang, Y.C. Wang, T.C. Liu, Y.H. Wang, Y.J. Lee, K.T. Lin (Chang Gung Memorial Hosp and University, Kaohsiung County, Taiwan) |
| P-205 THE FREQUENCY AND CLINICAL SIGNIFICANCE OF DELAYED SEROLOGICAL TRANSFUSION REACTIONS IN KOREAN POPULATION |
| C. Kim, T. Park, E. Lee, H. Son (Pusan National University Hospital, Busan, South-Korea) |
| P-206 THE ANTI-D PROGRAMME - THE SOUTH AFRICAN EXPERIENCE |
| P. Fogg, E. Smart, C. Olsen, V. Somerset, V. Poovalingam (South African National Blood Service ECR, Durban, South Africa) |
| P-207 DEVELOPMENT OF A MONOCLONAL ANTI-GLOBULIN REAGENT |
| H. Fraser, A. Mackie, D.A. Colligan, R.G. Drake, E. Shakir, J. Robb, A.G. Robb (Scottish National Blood Transfusion Serv, Glasgow, United Kingdom) |
| P-208 THE IMPORTANCE OF USING A COMBINATION OF D-TYPING METHODS AND REAGENTS IN PATIENTS |
| E. Kostopoulou, E. Hassapopoulou, E. Ntinopoulou, V. Bakaloudi, P. Chalkia, V. Avgoloupi, P. Didoudi, S. Intzepeli, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece) |
| P-209 SIGNIFICANT DIFFERENCES IN THE SENSITIVITY OF DIFFERENT GEL CENTRIFUGATION TECHNIQUES |
| V. Kretschmer, M. Bornmann, K. Schmidt, R. Karger (Institute Transfus. Med. Haemostaseol., Marburg, Germany) |
| P-210 COMPARATIVE ANALYSIS OF THE ABO AND RH CDE PHENOTYPE FREQUENCIES AMONG VARIOUS ETHNIC GROUPS IN PORT HARCOURT, NIGERIA |
| A. Jeremiah, I. Buseri (Rivers State University of Sci & Tech, Port Harcourt, Nigeria) |
| P-211 PARTIAL D (DNB) IN A PREGNANT WOMAN WITH RHD POSITIVE SEROLOGY AND DEVELOPMENT OF ANTI-D: CASE REPORT |
| V. Drazic, J. Mikulandra-Mratinovic, J. Bingulac-Popovic, S. Dajak, I. Babic, M. Balija, I. Jukic (Croatian Institute of Transfusion Medic, Zagreb, Croatia) |
| P-212 A COMPARISON OF CONVENTIONAL TUBE TECHNIQUE AND GEL TECHNIQUE IN EVALUATION OF DIRECT ANTIGLOBULIN TEST |
| D. Khetan, R. Chaudhary, S. Das (SG Postgraduate Institute of Medical Sci, Lucknow, India) |
| P-213 BLOOD GROUPING AUTOMATION IN A BLOOD TRANSFUSION CENTER |
| V. Fakitsa, M. Papakonstantinou, A. Flangini, K. Maltezis, I. Flessiopoulou, G. Lyrakos, S. Giannoulea, H. Desilla, C.H. Antoniou, P. Alexiou, T. Micha, E. Sotiropoulou, K. Sofroniadou (District General Hospital of Nikea, Athens, Greece) |
| P-214 ISOLATED MOTHER/CHILD MISMATCH IN THE RH SYSTEM |
| E.M. Dauber, M. Klintschar, D. Mayr, W.R. Mayr (Medical University of Vienna, Vienna, Austria) |
| P-215 DIRECT COOMBS (DAT) IN NEWBORN CHILDREN WITH HEAMOLYTIC JAUNDICE |
| E. Kostopoulou, E. Hassapopoulou, E. Ntinopoulou, P. Chalkia, S. Intzepeli, V. Avgoloupi, P. Didoudi, V. Bakaloudi, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece) |
| P-216 ANTI-Mg FOUND IN ABO TEST REAGENT OF HUMAN ORIGIN - CASE REPORT |
| R. Djordjevic, S. Draskovic, M. Sindjic, S. Tadic, M. Jovicic, Z. Smiljkovic, N. Tijanic, O. Ciric (National Blood Transfusion Institute, Belgrade, Serbia and Montenegro) |
| P-217 DRB1 ALLELES IN ARGENTINIAN PATIENTS WITH CHAGAS DISEASE |
| S. García Borrás, O. Pellizon, C. Cotorruelo, C. Biondi, J. Beloscar, O. Bottasso, C. Diez, A. Racca (Facultad de Ciencias Bioquímicas, Rosario, Argentina) |
| P-218 CLASSIFICATION OF PARTIAL D VARIANTS BY SEROLOGICAL AND MOLECULAR METHODS |
| S.S. Kulkarni, K. Vasantha, S.C. Gupte, D. Mohanty, K. Ghosh (Institute of Immunohaematology, Mumbai, India) |
| P-219 APLICATION OF FLOW CYTOMETRY IN DETERMINATION OF SUB-POPULATION OF RED BLOOD CELL |
| N. Lebensohn, L. Di Tullio, J. Valverde, P. Foresto (Fac. Cs. Bioquímias y Farmacéuticas - UNR, Rosario, Argentina) |
| P-220 AN UNUSUAL CASE OF AN ANTIBODY TO A HIGH FREQUENCY ANTIGEN IN A PATIENT WITH A POSITIVE DAT AND FREE AUTOANTIBODY |
| E. Lee, M. Redman, R. Malde (National Blood Service, London, United Kingdom) |
| P-221 STANDARDIZATION OF FETAL DNA EXTRACTION FOR NON INVASIVE PRENATAL RHD TYPING |
| J. Legler, L. Liu, A. Ait Soussan, C.E. van der Schoot (University Clinics Goettingen, Goettingen, Germany) |
| P-222 IMPAIRED INTERACTION IN RHD/RHAG-ANKYRIN COMPLEX ACCOUNTS FOR RHD DEFICIENCY IN DEL PHENOTYPE |
| T.M. Lin, H.L. Eng, Y.F. Yang, T.C. Liu, Y.H. Wang, Y.J. Lee, K.T. Lin, Y.C. Wang (National Cheng Kung University, Tainan, Taiwan) |
| P-223 COMPARISON OF SCANGEL, DIAMED, IN-HOUSE SPAT AND TUBE LISS ANTIGLOBULIN TEST FOR ANTIBODY DETECTION |
| L.A. Mohabir, C. Womersley (Welsh Blood Service, Pontyclun, United Kingdom) |
| P-224 FREQUENCY OF BLOOD GROUPS ABO AND RHESUS D IN THE GUINEAN POPULATION |
| A. Loua, M.R. Lamah, M. Camara (Centre National de Transfusion Sanguine, Conakry, Guinea) |
| P-225 CHARACTERIZATION OF A NOVEL B(A) ALLELE WITH BBBA TYPE AT THE ABO BLOOD GROUP |
| L. Lu, Q. Yu, Y.Q. Su, Z.H. Deng (ShenZhen Institute Of TransfusionMedicin, Shenzhen, China) |
| P-226 COMPARATIVE STUDY OF TUBE AND GEL TECHNIQUES FOR COMPATIBILITY TESTING AND ANTIBODY IDENTIFICATION |
| R.N. Makroo, S.G. Gautam (Apollo Hospitals, Delhi, India) |
| P-227 RHD GENE MOLECULAR VARIANTS IN THE WESTERN PART OF FRANCE : IDENTIFICATION OF 13 NEW ALLELES |
| C. le Marechal, C. Guerry, C. Benech, L. Burlot, F. Cordellier, M. Delamaire, C. Ferec (French Blood Center, Brest, France) |
| P-228 GENOTYPING OF DUFFY, KIDD, MNS BLOOD GROUPS : THE EFS PYRENEES MEDITERRANEE EXPERIENCE |
| C. Maugard, R. Aznar, N. Chikh, C. Segarra, O. Bouix, J. Coste (EFS Pyrénées Mediterranée, Montpellier, France) |
| P-229 ANTI-JK3 ALLOANTIBODIES IN THE PATIENT WITH JK NULL PHENOTYPE AND JKA/JKA GENOTYPE |
| E. Brojer, B. Michalewska, A. Kucmierz, M. Pelc-Klopotowska, A. Orzinska, H. Lopienska (Institute of Haematology and Blood Transfusion, Warsaw, Poland) |
| P-230 EVALUATION OF THE DIAGAST ERYTHROCYTES MAGNETIZED TECHNOLOGY |
| L.A. Mohabir, C. Womersley, Y. Barbreau, A.S. Degryse, J.M. Pelosin (Welsh Blood Service, Pontyclun, United Kingdom) |
| P-231 UNUSUAL ANTIBODY SPECIFICITY IN AN AFRICAN AMERICAN PATIENT WITH U-VARIANT RED BLOOD CELLS |
| C. Lomas-Francis, K. Hue-Roye, A. Fuchisawa, S.Y. Choo, C. m.d. Whitsett (New York Blood Center, New York, United States of America) |
| P-232 EVALUATION OF A NEW TECHNOLOGY FOR BLOOD GROUPING AND PHENOTYPING |
| M.A. Mota, M.G. Aravechia, V.L. Wakim, A.M. Sakashita, J.M. Kutner, L.M. Castilho (IEP/Hospital Albert Einstein, São Paulo, Brazil) |
| P-233 POST-TRANSFUSION HYPERHEMOLYSIS AFTER HEMOLYTIC TRANSFUSION REACTION IN A PATIENT WITH SEVERE ANEMIA: CASE REPORT |
| M.A. Mota, A.M. Sakashita, N. Hamerschlak, J.M. Kutner, L.M. Castilho (IEP/Hospital Albert Einstein, São Paulo, Brazil) |
| P-234 APPLICATION OF FY GENOTYPING TO DETERMINE BLOOD GROUP-SPECIFIC CHIMERISM AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION |
| M.A. Mota, A.A. Ciferri, R.A.A. Pereira, A.M. Sakashita, J.M. Kutner, L.M. Castilho (IEP/Hospital Albert Einstein, São Paulo, Brazil) |
| P-235 IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF HY AND JOA NEGATIVE BLOOD DONORS IN SOUTHERN USA |
| M. Moulds, W. Long, Q. Chen, M. Stone, D. Tulley, E. Lowery, A. Steinmetz, J. Moulds (LifeShare Blood Centers, Shreveport, United States of America) |
| P-236 ANTIBODY PREVALENCE IN A HETEROGENEOUS POPULATION OF PREGNANT WOMEN AND NEONATES |
| S. Mudahi-Orenstein, N. Lev, Y. Dakosta, O. Zelig, N. Manny (Hadassah Hebrew University Medical Center, Jerusalem, Israel) |
| P-237 DETECTION OF WEAK D TYPE 1, 2 AND 3 WITHIN WEAK D/C+ AND WEAK D/E+ RECIPIENTS IN DAILY PRACTICE : SEROLOGY, MOLECULAR BIOLOGY OR BOTH ? |
| F. Noizat-Pirenne, M. Verdier, A. Lejealle, A. Mercadier, A. Fialaire-Legendre, C. Tournamille, P. Bonin, P. Bierling, H. Ansart-Pirenne (Etablissement Français du Sang, Créteil, France) |
| P-238 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303 RBC FOR PATHOGEN INACTIVATION SUBSTANTIALLY REDUCES THE POTENTIAL FOR CROSS-REACTIVITY |
| A. North, G. Garratty, M.A. Schott, P. Arndt, G. Castro, A. Erickson, P. Mintz, L. Corash (Cerus Corporation, Concord, Ca, United States of America) |
| P-239 THREE NEW FUT1 ALLELES ENCODE DEFECTIVE FUCOSYLTRANSFERASES IDENTIFIED FROM PARA-BOMBAY PHENOTYPE INDIVIDUALS |
| K. Ogasawara, H. Tsuneyama, M. Uchikawa, S. Itou, K. Tadokoro, M. Satake, K. Nakajima (Red Cross Central Blood Institute, Tokyo, Japan) |
| P-240 A CASE OF SEVERE RH D ALLOIMMUNIZATION TREATED BY INTENSIVE PLASMA EXCHANGE AND HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN |
| P.M. Palfi, L. Matthiesen, J.O. Hilden, A. Selbing, G. Berlin (University Hospital, Linköping, Sweden) |
| P-241 MCLEOD PHENOTYPE - PHENOTYPE AND GENOTYPE IN A CASE OF MCLEOD SYNDROME WITH SEVERE NEUROLOGICAL SYMPTOMES |
| M. Písacka, L. Tilley, M. Kralova, J. Klempir, J. Roth (Instituteof Hematology and Blood Transfusion, Prague, Czech Republic) |
| P-242 MEDIATORS OF THE SELECTIVE CLEARANCE OF SENESCENT ERYTHROCYTES |
| A. Racca, C. Biondi, M.A. Ensinck, S. García Borrás, L. Racca, C. Cotorruelo (Facultad de Bioquímica, Rosario, Argentina) |
| P-243 RHMOD PHENOTYPE CAUSED BY DOUBLE HETEROZYGOSITY FOR TWO NEW ALLELES OF THE RHAG GENE |
| A. Scharberg, H. Tsuneyama, K. Ogasawara, M. Uchikawa, H.H. Keller, K. Panter, J. Senne, S. Penz, E. Richter, P. Bugert (DRK-BSD Baden-Wuerttemberg-Hessen, Baden-Baden, Germany) |
| P-244 OUR EXPIRIENCES IN TYPING AND SCREENING RED CELL ALO-ANTIBODIES IN SERA OF PATIENTS WHO ARE TESTED BY THE COLUMN AGGLUTINATION TECHNOLOGY ANTI-HUMAN GLOBULIN TEST |
| B. Stankovic, M. Trkuljic (Institute of Transfusiology, Belgrade, Yugoslavia) |
| P-245 B-CELL MEMORY AGAINST RHD ANTIGEN IN HYPERIMMUNIZED DONORS IS MAINLY PRESENT IN A CD27 NEGATIVE IGM POSITIVE B-CELL SUBSET |
| C.E. van der Schoot, C.E. van der Schoot, L.J. Gruneberg, O.H.M. Verhagen, G. Vidarsson, S.E. Dohmen (Sanquin Research, Amsterdam, Netherlands) |
| P-246 O BLOOD GROUP, WHERE ART THOU? |
| A. Seltsam, C. Figueiredo, C. Das Gupta, O. Bock, R. Blasczyk (Hannover Medical School, Hannover, Germany) |
| P-247 THE INCIDENCE OF DCE RH PHENOTYPE IN NAKASERO BLOOD BANK DONORS |
| P. Senyonga (Uganda Blood Transfusion Service, Kampala, Uganda) |
| P-248 RBC ALLOANTIBODIES FREQUENCY IN PREGNANT WOMEN |
| L. Suput-Tomas, M. Paunovic, B. Jankovic-Orescanin, G. Buric (Clinical-Hospital Center "Zvezdara", Belgrade, Serbia and Montenegro) |
| P-249 PROJECT IN DEVELOPING PANEL CELLS FOR ANTIBODY SCREENING AND IDENTIFICATION IN INDONESIA |
| R.S.E.G. Sjavitri Evi Gantini, T.H. Titik Herniwati, R.L. Crookes, M.R. Muhammad Rizal (CBTS Indonesian Red Cross, Jakarta, Indonesia) |
| P-250 A REVIEW OF THE CLINICAL SIGNIFICANCE OF ANTI-RH19 AND ANTI-RH34 ANTIBODIES DETECTED IN SOUTH AFRICAN PATIENTS |
| E.A. Smart, P. Fogg, S. Nadesan, I. Joseph (South African National Blood Service, EC, Durban, South Africa) |
| P-251 USING NON-TRADITIONAL QUALITY TOOLS TO EVALUATE AUTOMATION FOR PRETRANSFUSION TESTING |
| F. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America) |
| P-252 THE FIRST TWO CASE REPORTS OF ANTI-JAHK (RH53) IN PREGNANT WOMEN |
| A. Scharberg, K. Panter, J. Senne, S. Penz, E. Richter, G. Bojarsky, M. Leuteritz (DRK-BSD Baden-Wuerttemberg-Hessen, Baden-Baden, Germany) |
| P-253 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN IN THE MNS BLOOD GROUP SYSTEM, TD |
| M. Uchikawa, H. Tsuneyama, K. Ogasawara, Y Suzuki, R. Yabe, T Enomoto, M Satake, K Nakajima (Tokyo Blood Center, Tokyo, Japan) |
| P-254 THE EVALUATION OF GENOTYPES OF LEWIS BLOOD GROUP IN KOREAN USING DIRECT SEQUENCING AND RFLP. |
| I.B. Suh, S.W. Ryu, J.S. Kim, C.S. Lim, C.K. Lee, Y. Cho, Y.K. Kim, K.N. Lee (Kangwon Natl. Univ, Medical Science Inst, Chunchun, South-Korea) |
| P-255 IDENTIFICATION OF A NOVEL A1V-O1V HYBRID ALLELE WITH G829A MUTATION IN A CHIMERIC INDIVIDUAL OF AELBEL PHENOTYPE |
| C.F. Sun, D.P. Chen, W.T. Wang, J.P. Liu (Chang Gung Memorial Hospital, Tao-yuan, Taiwan) |
| P-256 EVALUATION OF MICROPLATE SYSTEM FOR ABO AND RH(D) BLOOD GROUPING |
| J.S. Shukla, R. Chaudhary, D. Khetan, A. Sonker (SG Postgraduate Institute of Medical Sci, Lucknow, India) |
| P-257 INVESTIGATIONS ON THE ROLE OF ANTIBODY FRAMEWORK SEQUENCES, AS DETERMINED BY VH GERMLINE GENE USAGE, ON ANTI-D ACTIVITY |
| S.J. Thorpe, C. Ball, B. Fox, R. Thorpe, K.M. Thompson, A.F. Bristow (NIBSC, Potters Bar, United Kingdom) |
| P-258 THE NUMBER OF REPEATS IN THE CBF/NF-Y ENHANCER VNTR REGION DOES NOT INFLUENCE THE LEVEL OF ABO TRANSCRIPTS IN BLOOD AND ERYTHROPOIETIC CULTURE |
| I. Thuresson, H. Dykes, T. Olofsson, L. Olsson, M. Chester (Department of Laboratory Medicine,, Lund, Sweden) |
| P-259 IMPORTANCE OF IMMUNEPROPHYLAXIS FOR HEMOLYTIC DISEASE OF THE NEWBORN |
| O.W. Torres, F. Oliveto, M. Direne (Maternidad Sardá, Buenos Aires, Argentina) |
| P-260 MOLECULAR BASIS FOR A NOVEL LOW-FREQUENCY ANTIGEN IN THE KELL BLOOD GROUPP SYSTEM, KYO |
| M. Uchikawa, T. Onodera, K. Ogasawara, H. Tsuneyama, C. Toyoda, R. Yabe, T Enomoto, M Satake, K Nakajima (Tokyo Blood Center, Tokyo, Japan) |
| P-261 MOLECULAR GENETIC ANALYSIS OF FUT1 AND FUT2 GENE IN PARA-BOMBAY CHINESE: A NOVEL FUT1 ALLELE IS IDENTIFIED |
| Y.Q. Su, T.L. Wei, Q. Yu, G.G. Wu, Y.L. Liang, S.Z. Ging (ShenZhen Institute Of Transfusion Medicine, Shen Zhen, China) |
| P-262 ALLOIMMUNISATION IN D NEGATIVE WOMEN FOLLOWING ROUTINE ANTENATAL ANTI-D IMMUNOGLOBULIN PROPHYLAXIS (RAADP) IN THE NORTH EAST OF SCOTLAND: A FIVE-YEAR RETROSPECTIVE STUDY |
| J. Urbaniak, A. Greiss, C. Promwong, R. Witterick, J. Burnett (University of Aberdeen, Aberdeen, United Kingdom) |
| P-263 ASSESSEMENT OF IRREGULAR RED CELL ALLOANTIBODIES IN VOLUNTARY BLOOD DONORS |
| E. Velkova, T. Makarovska-Bojadzieva, A. Hristova-Dimceva, I. Nikoloska, J. Angelovski, K. Dimitrovski, V. Stefanovska (Institute of Transfusion Medicine, Skopje, Macedonia) |
| P-264 STUDY ABOUT THE FUT2 GENE STRUCTURE OF XINJIANG UIGHUR AND HAN NATIONALITY |
| W. Wei, S. Su (Transfusion Medicine, Shenzhen, China) |
| P-265 NOVEL JKNULL ALLELES IN INDIVIDUALS OF DIFFERENT ETHNIC ORIGINS |
| S. Wester, T. Johnson, T. Copeland, R. Storry, L. Olsson (Blood Centre, Lund, Sweden) |
| P-266 TYPING DISCREPANCIES REVEAL TWO NEW KELNULL MUTATIONS IN THE INTRONS FLANKING EXON 8 |
| S. Wester, C. Ligthart, M.T. Steffensen, M. de Haas, R. Storry, M.L. Olsson (Blood Centre, Lund, Sweden) |
| P-267 ADSORPTION OF ANTIBODIES USING DIFFERENT ADSORPTION TECHNIQUES |
| J. de Wildt-Eggen, A. Scholten, J. Ebelties, M.J. Dijkstra-Tiekstra, E. Adema (Sanquin Blood Bank North East, Groningen, Netherlands) |
| P-268 BLOOD CHIMERISM LIMITED TO ONE OF THE TWINS |
| E.M. Dauber, C. Wolf, A. Leo, W.R. Mayr (Medical University of Vienna, Vienna, Austria) |
| P-269 DUFFY ANTIGEN EXPRESSION ON RETICULOCYTES DOES NOT ALTER FOLLOWING BLOOD LOSS IN AN AUTOLOGOUS DONATION MODEL |
| M. Wood, C. Brown, P. Hutchinson, V. Markovska, I.J. Woolley (Australian Red Cross Blood Service, Melbourne, Australia) |
| P-270 FY EXPRESSION IS INCREASED IN SOUTHEAST ASIAN OVALOCYTOSIS |
| J. Woolley, P. Hutchinson, J. Kazura, J. Reeder, A. Cortes (Monash Medical Centre, Clayton, Australia) |
| P-271 THE ELUCIDATION OF MOLECULAT GENETIC BASIS FOR TEN NOVEL ABO BLOOD GROUP ALLELES IDENTIFIED IN CHINESE POPULATION |
| G.G. Wu, Q. Yu, Z.H. Deng, Y.L. Lian, Y.Q. Su (Shen-Zhen Institute of Transfusion Medic, Shen-zhen, China) |
| P-272 A FAMILY INVESTIGATION OF A WEAK D TYPE 15 DONOR |
| W. Xiong, B.Ch. Yang, C.P. Shao (Shenzhen Blood Center, Shenzhen, China) |
| P-273 GENERATION OF RHD-CE(2~9)-D ALLELE BY GENE CONVERSION IN CIS |
| W. Xiong, C.P. Shao, B.Ch. Yang (Shenzhen Blood Center, Shenzhen, China) |
| P-274 IGNT (GCNT2) MUTATION ANALYSIS OF ADULT I PHENOTYPE IN ISRAEL: DETECTION OF A NOVEL MUTATION |
| V.B. Yahalom, E. Pras, R. Goldman-Levi, A. Abu, O. Asher, D. Zadok, C. Levene, I. Avni, E. Shinar (Magen David Adom - NBS, Ramat Gan, Israel) |
| P-275 HLA ANTIGENS IN IRANIAN MAJOR BETA-THALASSEMIC PATIENTS |
| F. Yari, M. Sobhani, F. Sabaghi, M. Zaman vaziri (Iranian Blood Transfusion organization, Tehran, Iran) |
| P-276 MOLECULAR POLYMORPHISM OF O ALLELES IN CHINESE HAN POPULATION |
| Q. Yu, Z.H. Deng, Y.L. Liang, G.G. Wu, Y.Q. Su, D.M. Wang (ShenZhen Institute Of TransfusionMedicin, Shenzhen, China) |
| P-277 THE MOLECULAR BACKGROUND AND POLYMORPHISM OF DEL IN CHINESE |
| Z. Zhu, Q. Li (Shanghai Blood Center, Shanghai, China) |
| P-278 MOLECULAR AND FAMILY ANALYSES REVEALED TWO NOVEL ALLELES IN A SURVEY OF A CHINESE TRUE D– POPULATION |
| Z. Zhu, L. Ye, Z. Guo, Q. Li (Shanghai Blood Center, Shanghai, China) |
| P-279 IMPORTANCE OF NONINVASIVE FETAL GENE EXAMINATION IN ALLOIMMUNIZED MOTHERS |
| B. Zupanska, A. Orzinska, M. Nowaczek-Migas, K. Guz, A. Gibala, J. Rumas-Bec, E. Brojer (Institute of Haematol.& Blood Transfusion, Warsaw, Poland) |
| P-280 APPROACH TO A PATIENT WITH RED CELL AUTO AND ALLOANTIBODIES-CASE REPORT |
| T.M. Makarovska-Bojadzieva (National Institute of Blood Transfusion, Skopje, Macedonia) |
| P-281 THE USE OF GLYCATED HAEMOGLOBIN (HBA1C) FOR MONITORING DIABETIC CONTROL IN NNEWI, SOUTH-EAST NIGERIA |
| E.C. Okocha, A.L. Asomogha, R.N. Asomogha (Nnamdi Azikiwe University, Nnewi, Nigeria) |
| P-282 TRANSFUSION OF NORMAL BLOOD TO PATIENTS WITH RARE ADULT I PHENOTYPE |
| M Lin, Y.S. Chan, C.L. Wang, E.J. Hsueh (Mackay Memorial Hospital, Taipei, Taiwan) |
| P-283 BLOOD GROUP GENOTYPES IN IRANIAN THALASSEMIC PATIENTS & SOME BLOOD DONORS |
| M. Shaiegan, A. Azarkeivan, S. Samiei, Z. Ataee, M. Kavari, H. Lotfi, P. Lotfi (IBTO Research Center, Tehran, Iran) |
| TOPIC 02.2 |
| Topic 02.2. |
| Red Cells - Immune Haemolytic Anaemias |
| P-284 ADVERSE HAEMOLYTIC TRANSFUSION EVENTS: CONSIDER THE ROLE OF DRUGS |
| A.G. van den Bos, J. Gerrits-Kuiper, M.H.P.O. Moors, V.M.J. Novotny (Radboud University Medical Center, Nijmegen, Netherlands) |
| P-285 APPLICATION OF FLOW CYTOMETRY IN DETECTION OF RED CELL BOUND IGG IN AIHA: COMPARISON WITH CONVENTIONAL TUBE TECHNIQUE AND GEL TEST |
| R. Chaudhary, S. Das, R. Gupta (SG Postgraduate Institute of Medical Sci, Lucknow, India) |
| P-286 ABO-HEMOLYTIC DISEASE OF THE NEWBORN (HDN): TWO YEARS OF EXPERIENCE |
| M. Garcia Rosasco, G. Bassani, J. Valverde (National University of Rosario, Rosario, Argentina) |
| P-287 CLINICAL RELEVANCE OF NON-RHESUS-D-IEA TITER AND MONOCYTE-DRIVEN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TEST RESULT FOR THE PREDICTION OF SEVERE HAEMOLYTIC DISEASE OF THE NEWBORN. |
| M. de Haas, K. Bilgin, T. Vrijkotte, J.M. Koelewijn, M.A.M. Overbeeke, C.E. Van der Schoot, G.J. Bonsel (Sanquin, Amsterdam, Netherlands) |
| P-288 NON-INVASIVE FETAL RHD GENOTYPING AND FETAL SEXING IN MATERNAL BLOOD |
| M. de Haas, B.E.M. Bossers, A. Ait Soussan, P.C. Ligthart, L.D.M. Schuitemaker, G.C.M.L. Page-Christiaens, C.E. Van der Schoot (Sanquin, Amsterdam, Netherlands) |
| P-289 IMMUNE HEMOLYSIS AFTER LIVER TRANSPLANTATION |
| Z. Hundric-Haspl, N. Jurakovic-Loncar, M. Tomicic, M. Balija, I. Jukic (Croatian Institute of Transfusion Medici, Zagreb, Croatia) |
| P-290 CLINICAL OUTCOMES OF ABO INCOMPATIBLE RED BLOOD CELL (RBC) TRANSFUSIONS |
| N.D. Kalmin, K. Janatpour, H.M. Jensen, P.V. Holland (South Texas Blood & Tissue Center, San Antonio, United States of America) |
| P-291 EVALUATION OF THE SENSITIVITY OF THE DIRECT ANTIGLOBULIN TEST (DAT) BY THE ROUTINE SEROLOGICAL TUBE TEST (DAT-T) AND BY THE MICROCOLUMN GEL TEST (DAT-G) FOR WARM-TYPE AUTO-IMMUNE HAEMOLYTIC ANAEMIA (AIHA) DIAGNOSTICS |
| E.K. Klausa, S.B. Bochenek, A.M. Misiaszek (Regional Centre of Transfusion Medicine, Wroclaw, Poland) |
| P-292 PREDICTIVE VALUE AND SENSITIVITY OF FIRST TRIMESTER SCREENING FOR IRREGULAR ERYTHROCYTE ANTIBODIES TO DETECT NON-RHESUS-D-IEA-MEDIATED HAEMOLYTIC DISEASE OF THE NEWBORN IN THE NETHERLANDS |
| J.M. Koelewijn, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel, M. de Haas (Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands) |
| P-293 RISK FACTORS FOR RHESUS-D-IMMUNIZATION DESPITE POSTAND ANTENATAL ANTI-D-PROPHYLAXIS |
| J.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, C.E. van der Schoot, G.J. Bonsel (Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands) |
| P-294 AETIOLOGICAL FACTORS RELATED TO A POSITIVE DIRECT ANTIGLOBULIN TEST (DAT) IN HIV INFECTED PATIENTS |
| M. Lai, G. D'Onofrio, E. Visconti, E. Tamburrini, R. Cauda, G. Leone (Catholic University Immunohematology Lab, Roma, Italy) |
| P-295 LOWER HEMOGLOBIN LEVELS IN DAT POSITIVE HIV POSITIVE PATIENTS, ITS RELATIONSHIP WITH THE AGGLUTINATON STRENGHTS AND DIFFERENCES IN THE CLINICAL STAGES |
| M. Lai, E. Visconti, G. D'Onofrio, E. Tamburrini, R. Cauda, G. Leone (Catholic University Immunohematology Lab, Roma, Italy) |
| P-298 A FAMILY OF HEMOLYTIC DISEASE OF THE NEWBORN FOR TWO GENERATIONS POTENTIALLY DUE TO ANTI-KG |
| J. Takahashi, S. Kubo, H. Takahashi, M. Hirashima, T. Ezaki, K. Kimura, M. Tsuzi, T. Nakade, M. Horie, Y. Tomorari, H. Matsukura, F. Hirayama, K. Tsubaki, H. Minowa, Y. Tani, H. Shibata (Japanese Red Cross Osaka Blood Center, Osaka, Japan) |
| P-299 GRAFT VERSUS HOST ANTI-RH(D) FOLLOWING RH-INCOMPATIBLE ORTOTOPTIC LIVER TRANSPLANTATION (OLT): A CASE REPORT |
| D. Venturelli, M. Masetti, L. Bensi, M.G. Baldini, G. Gerunda, M. de Palma (Azienda Policlinico, Modena, Italy) |
| P-300 ANTI-M IMMUNIZATION: A POSSIBLY UNDERDIAGNOSED CAUSE OF FETAL HEMOLYTIC ANEMIA AND INTRAUTERINE DEATH |
| A. Wikman, A. Edner, G. Gryfelt, B. Jonnson, J.I. Henter (Karolinska University Hospital, Stockholm, Sweden) |
| P-301 THE ASSOCIATION OF FCGAMMA RECEPTOR IIA (CD32) POLYMOPHISM AND IGG SUBCLASS CONCENTRATION IN MATERNAL SERUM IN ABO HEAMOLYTIC DISEASE OF NEWBORN |
| Y. Zhang, M. Liu, S. Liu (Blood Reseach Lab, Xi'an, China) |
| TOPIC 02.3 |
| Topic 02.3. |
| Red Cells - Antigen Modification |
| P-302 ANIMAL TRIALS OF MPEG MODIFIED RED BLOOD CELLS |
| Y. Qiu (Beijing Red Cross Blood Center, Beijing, China) |
| P-303 EFFECTS OF SYNTHETIC POLYCATIONS ON ERYTHROCYTE MEMBRANE ANALYZED BY OPTICAL METHODS |
| D. Riquelme, P. Grandfils, B. Fontana, M. Alessi, R. Valverde, G. Foresto, F. Relancio, F. Stoltz, A. Dumas (Fac. de Cs. Bioquímicas y Farmacéuticas, Rosario, Argentina) |
| P-304 ABNORMAL GLYCOSILATION OF ABH ANTIGENS IN HUMAN SPERM AND ITS RELATIOSHIP WITH DNA DAMAGE ASSESED BY (TDT- MEDIATEDDUTP- NICK END LABELING) TUNEL ASSAY IN INFERTILE MEN |
| A.S. Brufman, Ch. Chaingam, E.A. Solis, E.G. Orellano (National University of Rosario, Rosario, Argentina) |
| P-305 THE CA19-9 ANTIGEN AND THE LEWIS STATUS OF PATIENTS WITH RENAL PELVIS DILATATION |
| G Koritsiadis (Athens University, Laiko Gnrl Hospital, Athens, Greece) |
| TOPIC 02.4 |
| Topic 02.4. |
| Red Cells - Transfusion |
| P-306 A FORTUITOUS BENEFIT OF RED BLOOD CELL EXCHANGE IN TREATMENT OF A CHILD WITH ACUTE CHEST SYNDROME |
| C.F.M. Danielson, M. Heiney, W. Jackson, M. Skipworth, A. Miguel, L.J. McCarthy (Wishard Memorial Hospital, Indianapolis, United States of America) |
| P-307 A MODIFIED TREATMENT PROCESS FOR PREPARATION OF S-303 RBC FOR PATHOGEN INACTIVATION IN THREE DIFFERENT ADDITIVE SOLUTIONS MAINTAINS RBC FUNCTION |
| A. Erickson, M.A. Schott, V.A. Lee, G.M. Castro, T. Peterson, A. North (Cerus Corporation, Concord, United States of America) |
| P-308 HYPERHEMOLYSIS SYNDROME |
| V. Fakitsa, M. Papakonstantino, A. Flangini, F. Drini, G. Lyrakos, K. Maltezis, P. Stasinopoulou, L. Haliou, E. Erotokritou, K. Sofroniadou, M. Drosou (District General Hospital of Nikea, Athens, Greece) |
| P-309 RETROSPECTIVE ANALYSIS OF TRANSFUSION RATE IN HIP FRACTURE SURGERY |
| V. Fakitsa, K. Maltezis, M. Papakonstantinou, J. Maniakis, T. Micha, E. Sotiropoulou, A. Flangini, F. Drini, N. Prevezas (District General Hospital of Nikea, Athens, Greece) |
| P-310 ERYTHROCYTAIRE CHARGE SURFACE PROPERTIES DURING STORAGE |
| P. Foresto, N. Lebensohn, M. D'Arrigo, J. Valverde (Fac. Cs. Bioquímias y Farmacéuticas - UNR, Rosario, Argentina) |
| P-311 THE ESTABLISHMENT OF RED CELL BLOOD TYPE DATA BANK FOR MN, P, KIDD, DUFFY AND LEWIS ANTIGEN SYSTEMS |
| M. Liu, S. Ye, J. Qi (Blood Center of Shaanxi Province China, Xi`an, China) |
| P-312 EVALUATION OF PRODUCT QUALITY AND DONOR SAFETY FOLLOWING DOUBLE UNIT RED CELL APHERESIS USING THE ALYX COMPONENT COLLECTION SYSTEM |
| A. Sen, K. Chatterjee (Armed Forces Transfusion Centre, New Delhi, India) |
| P-313 EDUCATION OF NURSES IN TRANSFUSION THERAPY |
| D. Sovic (University Hospital, Zagreb, Croatia), J. Dodig (University Hospital "Sestre Milosdrnice", Zagreb, Croatia) |
| P-314 THE IMPLEMENTATION OF RESTRICTIVE STRATEGY FOR PRBCS TRANSFUSION IN TREATMENT OF CARDIAC SURGERY PATIENTS |
| E. Ambarkova Vilarova, M.Z. Mitrev, M. Blagoevska, C.A. Crvenpanova (Special Hospital for Cardiosurgery, Skopje, Macedonia) |
| P-315 IMPROVING BLOOD TRANSFUSION PRACTICE IN A DISTRICT GENERAL MATERNITY UNIT |
| R. Mudenha, R. Lindsay, V. Rodie, A. Todd, A.J. Thomson (Royal Alexandra Hospital, Glasgow, United Kingdom) |
| P-316 HAEMOVIGILANCE: DETECTION OF ADVERSE REACTIONS ASSOCIATED WITH BLOOD TRANSFUSION |
| Z. Cermakova (Faculty Hospital, Ostrava, Czech Republic) |
| P-317 A FATAL CLINICAL DILEMMA MIMICKING AN INTRAVASCULAR HAEMOLYTIC TRANSFUSION REACTION |
| R. Sinha (Singh), D. Roxby (Flinders Medical Centre, Adelaide, Australia) |
| P-318 TRANSFUSED BLOOD COMPONENTS VERSUS THE RESERVED FOR SURGICAL PATIENTS |
| S. Ortakovska, M. Balamovski, T. Timova, M. Blagoevska, R. Grubovic (General Hospital, Gevgelija, Gevgelija, Macedonia) |
| P-319 BLOOD TRANSFUSION PRACTICE-PUBLIC VERSUS PRIVATE HOSPITALS |
| T.M. Makarovska-Bojadzieva, M. Blagoevska, J. Samonikov-Tosevska, R. Grubovik (National Institute of Blood Transfusion, Skopje, Macedonia) |
| P-321 ONTARIO NURSE TRANSFUSION COORDINATORS (ONTRAC): A PROVINCIAL BLOOD CONSERVATION PROGRAM |
| J. Freedman, K. Luke, M. Escobar, M.B. Garvey, J.A. Chiavetta (St Michael's Hospital, Toronto, Ontario, Canada) |
| P-322 RED CELL TRANSFUSION IN POLAND - A NATIONAL SURVEY |
| A. Rosiek, A. Dzieciatkowska, M. Letowska (Institute of Hematology, Warsaw, Poland) |
| P-323 COMPARISON OF OPERATOR PROCESSES FOR PRETRANSFUSION TESTING ON THE ORTHO AUTOVUE INNOVA, GALILEO, AND CLASSIC ID-GEL STATION USING FAILURE MODES AND EFFECTS ANALYSIS |
| F. South, T. Casina, W. Malomgre (Ortho-Clinical Diagnostics, Scottsdale, United States of America) |
| P-324 HAEMOGLOBINOPATHIES IN BLOOD DONORS FROM YOGYAKARTA, INDONESIA; MOLECULAR MUTATION AND THEIR IMPLICATION TO BLOOD TRANSFUSION PRACTICE |
| M. Sofro, F. Lanni (YARSI University, Jakarta, Indonesia) |
| P-325 RED BLOOD CELLS TRANSFUSION AT THE OBSTETRIC AND GYNECOLOGIC DEPARTMENT OF THE CLINICAL HOSPITAL CENTER ZVEZDARA IN BELGRADE |
| J.O.B. Jankovic Orescanin (Clinical Hospital Center Zvezdara, Belgrade, Serbia and Montenegro) |
| P-326 THE MAJOR INTEGRAL PROTEINS OF RBCS LIPID RAFTS DURING STORAGE |
| A. Kriebardis, M. Antonelou, K. Stamoulis, E. Economou-Petersen, L. Margaridis, I. Papassideri (University of Athens, Athens, Greece) |
| P-327 IRREGULAR ANTIBODIES TO RED BLOOD CELLS IN PATIENTS ON CHRONIC HAEMODIALYSIS |
| G.P. Poposki, V.T. Tomanoski, S.M. Mena (Institute of Nephrology, Struga, Macedonia) |
| P-328 EMPOWERMENT OF LABORATORY STAFF TO IMPLEMENT LOCAL GUIDELINES IS HIGHLY EFFECTIVE IN PREVENTING INAPPROPRIATE TRANSFUSIONS AND ENABLES BLOOD CONSERVATION |
| J. Watts, D. Stokes, D. Green, T. Turner (Basildon University Hospital, Basildon, United Kingdom) |
| P-329 NEW ADDITIVE SOLUTION FOR IMPROVED STORAGE OF RED BLOOD CELLS (RBC) |
| M. Löf, C.F. Högman (University Hospital, Uppsala, Sweden) |
| P-330 EXTENDED RED CELL ANTIGEN TYPING OF BLOOD DONORS USING THE PK7200 |
| S. Valensky (Western Province Blood Transfusion Servi, Cape Town, South Africa) |
| P-331 COMPARISON OF IN VITRO BLOOD COMPONENT QUALITY USING TWO DIFFERENT DESIGN BUTANE-1,4-DIOL COOLING SYSTEMS |
| P.F. van der Meer, M. Eijzenga, W. Karssing, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| P-332 INVESTIGATION OF MIXING OF WHOLE BLOOD UNDER VARIOUS FLOW RATES USING THE HEMOLIGHT PLUS COLLECTION MIXER |
| P.F. van der Meer, I.J. Bontekoe, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| P-333 ARE UK GUIDELINES FOR PROVISION OF BLOOD FOR PATIENTS WITH SICKLE CELL DISEASE FOLLOWED? |
| J.L. White, C.E. Milkins, D. Benkhaled, M. Rowley (UK NEQAS (BTLP), Watford, United Kingdom) |
| P-334 THE USE OF BLOOD AND BLOOD COMPONENTS IN THE ORTHOPEDIC DEPARTMENT DURING YEAR 2005 |
| E. Kocovska, M. Kocovski (Tetovo Hospital, Tetovo, Macedonia) |
| P-335 STORAGE OF WHOLE BLOOD INFLUENCES THE RESPONSE OF RED CELLS TO AN ALKALINE STORAGE MEDIUM |
| D. de Korte, H.G.H. Korsten, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-336 STORED RED CELL CONCENTRATES OF HEMOCHROMATOSIS PATIENTS: ARE THEY DIFFERENT? |
| M. Luten, B. Roerdinkholder-Stoelwinder, E. Rombout-Sestrienkova, H.J. Bos, W.J. de Grip, G.J.C.G.M Bosman, V.M.J. Novotny (Sanquin Blood Bank South East Region, Nijmegen, Netherlands) |
| P-337 EVALUATION OF THE IN VITRO QUALITY OF FROZEN AND THAWED RED CELLS PROCESSED WITH THE HAEMONETICS® ACP®215 |
| J.W.M. Lagerberg, R. Truijens-de Lange, D. de Korte, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-338 EFFECT OF THE PH ON THE ATP CONTENT AND GLYCOLITIC ACTIVITY OF THAWED RED CELLS |
| J.W.M. Lagerberg, R. Truijens-de Lange, D. de Korte, A.J. Verhoeven (Sanquin Research, Amsterdam, Netherlands) |
| P-339 CORRELATION BETWEEN REQUESTS OF BLOOD AND ITS PRODUCTS AND BLOOD TRANSFUSION IN A UNIVERSITY HOSPITAL IN GREECE |
| K. Zervou, K. Ziciadis, E. Xanthi, A. Tzolou, E. Chrisostomou, F. Karabini (University Hospital of Ioannina, Ioannina, Greece) |
| P-340 RED BLOOD CELL TRANSFUSION POSITIVELY IMPACTS SURVIVAL IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION |
| S.G. Ganguly, P. Bradley, S. Patel, L. Divine, S. Skikne, C. Bodensteiner (University of Kansas Medical Center, Kansas City, United States of America) |
| P-341 A CASE OF A PATIENT WITH MCLEOD PHENOTYPE AND CGD WHO DID NOT PRODUCE ANTI-KX REGARDLESS OF PACKED RED CELLS TRANSFUSIONS FROM RANDOM DONORS DURING NONMYELOABLATIVE CORD BLOOD TRANSPLANTATION |
| Y. Tani, J. Takahashi, F. Hirayama, N. Hatakeyama, M. Yamamoto, Y. Kuroiwa, N. Mizue, M. Yoda, Y. Sakiyama, N. Suzuki, H. Shibata (Japanese Red Cross Osaka Blood Center, Osaka, Japan) |
| P-342 MULTI-ETHNIC DONOR GENOTYPING ON THE COMMON SINGLE NUCLEOTIDE POLYMORPHISMS ENCODING RED BLOOD CELL ANTIGENS DOES NOT RELIABLY PREDICT RED BLOOD CELL PHENOTYPES |
| P. A. Maaskant - van Wijk, M. Feskens, J.D. van Wintershoven, L. Douglas-Berger, M. Bogaerts, D.J. van Rhenen (Sanquin Bloodbank Southwest Region, Rotterdam, Netherlands) |
| P-343 INCIDENCE OF ALLOIMMUNIZATION IN BLACKS FROM AFRICA VS. USA |
| M. Moulds, G. Noumsi, A. Tounkara, Y. Guindo, J.M. Moulds (LifeShare Blood Centers, Shreveport, La, United States of America) |
| P-344 RE-ESTABLISHING OF STORED RBC’S CHARACTERISTICS STUDIED BY FLOW CYTOMETRY |
| L. Di Tullio Budassi, F. Relancio, B. Riquelme, P. Foresto, J. Valverde (Fac. Cs. Bioq. y Farm - UNR, Rosario, Argentina) |
| P-345 RED BLOOD CELL PHENOTYPE DETERMINATION OF 2,345 NEW YORK BLOOD DONORS BY DNA ANALYSIS IN A BEADCHIP FORMAT |
| G. Hashmi, T. Shariff, J. Cristobal, Y. Zhang, C. Chau, M. Seul, P. Vissavajjhala, K. Hue-Roye, D. Charles-Pierre, C. Lomas-Francis, C. Baldwin, M. Reid (Bioarrays Solutions, Warren, United States of America) |
| P-346 ALLOIMMUNIZATION AGAINST RBC (RED BLOOD CELL) TRANSFUSIONS IN PATIENTS OF THE REGIONAL BLOOD BANK OF LONDRINA – PARANÁ - BRAZIL |
| M. Saito, M.R.S. Turra, A.N.J. Koti, K.M. Arai, L.G.F.T. Turkowski, C.C. Faune (Hemocentro Regional Londrina, Londrina, Brazil) |
| P-347 AUTOMATED DOUBLE VS. STANDARD RBC COLLECTION: CHARACTERICS OF PRODUCTS AND ITS CLINICAL EFFICACY |
| P. Accorsi, M. Dell'Isola, P. Striani, F. Esattore, S. Falorio, M. Profico, G. Di Bernardo, A. Iacone, P. Accorsi (Pescara Civil Hospital, Pescara, Italy) |
| P-348 HAEMOSTATIC DISORDERS IN PATIENTS WITH EPH-GESTOSIS |
| T.T. Timova, L. Maninska, S. Ortakovska, E. Kocovska, R. Madzunkov, S. Kostovska (General hospital-Strumica, Strumica, Macedonia) |
| TOPIC 03.1 |
| Topic 03.1. |
| Haemostasis - Recent Therapeutic Advances |
| P-349 PLATELET GEL IN POST-SURGICAL INFECTED WOUNDS HEALING IN HEART SURGERY |
| S. Misso, B. Feola, L. Paesano, M. D'Onofrio, G. Fratellanza, E. D'Agostino, E.M. Bruno, M. Nigro, A. Minerva (Unit Operative Haemapheresis, Caserta, Italy) |
| P-350 NEUROSURGERY IN A HEMOPHILIC CHILD WITH CENTRAL NERVOUS SYSTEM HEMORRHAGE |
| O.W. Torres, A.M. Ferro, S. Ouvina, S. Pascuccio, J. Pollola, G. Paoloski, D. Gercovich, A. Paz, M.A. Cermelj (William Osler Institute, Buenos Aires, Argentina) |
| P-351 RECOMBINANT FVII TREATMENT IN A HEMOPHILIA A PATIENT WITH HIGH TITER INHIBITOR AND CENTRAL NERVOUS SYSTEM HEMORRHAGE |
| O.W. Torres, A.M. Ferro, S. Ouvina, S. Pascuccio, J. Pollola, G. Paoloski, D. Gercovich, A. Paz, M.A. Cermelj (William Osler Institute, Buenos Aires, Argentina) |
| P-352 THROMBOPHILIC MARKERS FREQUENCY IN THE PATIENTS WITH DEEP VENOUS THROMBOSIS |
| B. Kostovska, M. Stegnar, V. Neceva, C. Dimova, J. Pejceva, M. Blazevska, L. Jamovski (Institute of blood Transfusion, Skopje, Macedonia) |
| Topic 03.2 |
| Topic 03.2. |
| Haemostasis - Related to Blood Transfusion |
| P-353 CRYOPRECIPITATE-REMOVED PLASMA 'CRYO-REMOVED PLASMA' AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B |
| P. Lepatan, M. Chua, F. Hernandez, M. Montoya, J. Ong, E. Rodriguez (Hemophilia Center of Cebu, Cebu, Philippines) |
| P-354 BERNARD SOULIER SYNDROM IN IRAN |
| F. Razjou (Iranian Blood Transfusion Research Centre, Tehran, Iran) |
| P-355 HAEMORHEOLOGICAL ALTERATIONS IN NIGERIAN TRANSFUSED PATIENTS |
| I. Ajayi (University of Benin, Benin City, Nigeria) |
| P-356 CORRECTION OF HEMOSTASIS SYSTEM IN PATIENTS WITH TYPHOID BLEEDINGS |
| B. Bahovadinov, A. Vahidov (Republican Sientific Centre of Blood, Dushanbe, Tajikistan) |
| P-357 THE USE OF RECOMBINANT FVIIA (RFVIIA) IN PATIENTS WITH UNCONTROLLABLE SURGICAL OR POST SURGICAL BLEEDING |
| P. Kotsi, M. Gavalaki, I. Anastasopoulou, O. Katsarou, G. Kanellopoulou, A. Karafoulidou (Laikon General Hospital, Athens, Greece) |
| P-358 ASSESSMENT OF FRESH FROZEN PLASMA USAGE AT THE CLINICAL HOSPITAL CENTER RIJEKA |
| N. Vukelic-Damijani, S. Balen, L. Caser (Clinical Hospital Center, Rijeka, Croatia) |
| P-359 FREQUENCY OF TRANSMISIVE VIRUS MARKERS AT HEMOPHILIANS IN CORELLATION WITH HEPATIC FUNCTION |
| S.K. Kostovska, V. Filipche, V.N. Neceva, P.J. Pejceva, I.S. Ilievska, D.V. Dejanova, D.N. Dimovska (Institute of Blood Transfusion, Skopje, |